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Abstract 
Objective: To evaluate and compare the effectiveness of using three different influenza 
immunization surveillance forms in accounting for all influenza vaccine distributed in a 
community setting. Methods: All family practice physicians and community health 
nurses (CHNs) in the Eastern Region ofNewfoundland ·and Labrador were randomly sent 
one ofthree influenza immunization surveillance forms: individual, tally or government. 
They were asked to: document case information about patients given influenza vaccine in 
the 2001-2002 season, return completed forms as well as unused vaccine, and provide 
feedback about the forms at the end of the study. Results: There was 100% participation 
by CHNs and 82.4% by physicians. Of the 13,310 doses of influenza vaccine distributed, 
7,645 (57.5%) doses we.re accounted for using the surveillance forms. Use ofthe 
government form accounted for statistically significantly more influenza vaccine than use 
of the tally and individual forms (p< 0.0005), while the tally form accounted for 
significantly more vaccine than the individual form (p< 0.0005). The tally and individual 
forms provided more information than the government form about those who received the 
vaccine. Feedback identified that health care professionals preferred less paper and 
fewer questions, but supported influenza immunization surveillance. Conclusion: The 
study's fmdings supports using a tally fom1 as a way to collect useful influenza 
immunization surveillance data in future influenza immunization seasons. 
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CHAPTER! 
Introduction 
Influenza is an acute respiratory illness which occurs worldwide and causes 
considerable morbidity and mortality each year. It is estimated that each year in Canada 
up to 75,000 hospitalizations and 6700 deaths are associated with influenza vims 
infection (Health Canada, 1993). Vaccination against the influenza virus is recognized to 
be the single most effective way of preventing or attenuating influenza for those at high 
risk of serious illness or death (Health Canada, 2000a). The groups most susceptible to 
complications related to influenza are: persons 65 years of age or older, persons with 
chronic cardiac or pulmonary disorders or other chronic conditions, residents of 
institutions, and children and adolescents with conditions treated for long periods of time 
with acetylsalicylic acid. The National Advisory Committee on Immunization (NACI) 
has identified these high risk groups, and health care professionals who could transfer 
influenza to these populations, as targets for annual immunization programs (Health 
Canada, 2000a). 
Realistically, influenza immunization programs should aim to vaccinate at least 
90% of eligible recipients (Health Canada, 2000a). Currently, influenza vaccination rates 
of eligible groups are much lower than the target rate of 90%, since vaccination rates of 
residents living in long term care facilities is only 70%, and only 20% to 40% of adults 
and children with medical conditions that leave them susceptible to complications related 
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to influenza, receive the vaccine annually (Duclos, Arruda, & Dessau, 1996; Dewals, 
Carbonneau, & Payette, 1996). Studies of health care workers in hospitals and long term 
care facilities have shown influenza vaccination rates of 26% to 61% (Potter, Stott, & 
Roberts, 1999; Wilde, McMillan, & Serwint, 1999; Nichol & Hauge, 1997). It is 
important to increase vaccination rates in order to decrease the impact of influenza and to 
help in preparing for pandemic influenza. 
Pandemic influenza planning is ongoing due to the threat of a predicted 
worldwide outbreak. This threat has created an interest in increasing influenza vaccine 
coverage rates as well as a need for more accurate influenza immunization data. It is 
therefore appropriate that officials in Newfoundland and Labrador implement a 
mandatory influenza immunization surveillance program to track influenza 
immunization. 
It is important for nurses and other health care professionals to enhance influenza 
vaccination promotion campaigns since annual fall campaigns have been helpful in 
increasing influenza vaccination coverage rates (Health Canada, 1993). The proportion 
of vaccine eligible groups receiving influenza vaccination must be determined in order to 
decide who the health promotion campaign should target. To calculate the proportion of 
vaccine eligible groups that receive influenza vaccine, the number of individuals 
vaccinated (numerator) is required, as well .as the number of individuals eligible 
(denominator). A surveillance system to account for the number of influenza vaccine 
doses administered, and to whom they are administered, will provide numerator data, 
while denominator data may be available from other areas, such as census data and 
disease registries. 
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Prior to the 2001-2002 season, in Newfoundland and Labrador, there was no 
influenza immunization surveillance system in place to determine the numerator data. 
Therefore this study implemented a surveillance system to account for the influenza 
vaccine distributed and administered. If the appropriate denominator data is available, a 
surveillance system will provide information about those who receive the influenza 
vaccine, so that health care professionals can focus influenza immunization promotion 
campaigns on target groups who fail to receive influenza vaccination. This should 
consequently lead to an increased influenza vaccination rate in eligible groups. A 
graphical representation of this process can be found in appendix A. 
Currently in Newfoundland and Labrador, the publically funded influenza 
immunization program covers those individuals identified by the NACI as high risk for 
complications as well as health care workers and essential service workers. Each year, 
vaccine is distributed across the province to public health units, nurses, physicians' 
offices, long term care facilities, and hospitals. In the 2001-2002 season there were 
.approximately 86,000 doses of influenza vaccine distributed across the province. The 
vaccine distributed, however, provides only a crude measure of the vaccination rate since 
the number of doses distributed does not equate to the actual number of doses 
administered, nor does it identify whether the vaccine was administered to the 
appropriate people. 
4 
In Newfoundland and Labrador, prior to the 2001-2002 season, there was no 
system available to track the number of doses of influenza vaccine administered in either 
the hospital or community settings. The number of doses of influenza vaccine 
administered in an institutional setting is much easier to determine compared to those in a 
community setting, since this data can be extracted from patient files or occupational 
health files. The only way the number of doses of influenza vaccine administered in a 
community setting had been determined was through counting the doses of vaccine 
distributed minus the doses of vaccine returned. This is not an accurate measure because 
many health care professionals fail to return unused vaccine (personal communication, 
Patricia Heath, Communicable Disease Control Coordinator Eastern Region, November 
24, 2002). It was therefore important to develop a surveillance system which would 
provide valid and reliable data and meet the seven criteria identified by the Centres for 
Disease Control (CDC) (2001) which are important to consider when evaluating a 
surveillance system. The seven criteria which are necessary for an efficient and effective 
system are: adequate sensitivity, adequate positive predictive value, simplicity, 
acceptability, flexibility, representativeness, and timeliness. 
In the 2001-2002 season a surveillance system was developed using one ofthree 
influenza immunization surveillance forms as a way to account for all influenza vaccines 
distributed in a community setting. Two of the surveillance forms, individual and tally 
forms, contained exactly the same information, but were presented in different formats. 
Heath care providers who completed the individual or tally form were required to provide 
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information on six items for each individual who received the vaccine. The third form, 
the government form, was sent out by the provincial government and only required the 
health care professional to indicate whether or not the individual was under or over 65 
years of age. This study evaluated the three surveillance forms according to the seven 
criteria identified by the CDC (200 1) to determine which form was most effective in 
providing information about the influenza doses distributed during the 2001-2002 season. 
This study also provided community health nurses and physicians with an opportunity to 
provide feedback about surveillance and the influenza immunization surveillance forms 
used in this study. 
Research Questions 
The research questions are: 
1. Which surveillance form (tally form, individual form, or government form) is the 
most sensitive in providing information about the number of doses of influenza 
vaccine administered and to whom? 
2 Which surveillance form provides the most complete and accurate data? 
3. Which surveillance form provides the most useful information about those who 
receive influenza vaccine? 
4. Which surveillance form is more acceptable to health care professionals? 
5. What factors influence health care professionals' participation in influenza 
immunization surveillance? 
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CHAPTER2 
Literature Review 
The literature review provides an overview of the influenza virus, and it's impact, 
and the effectiveness of influenza vaccine in preventing and attenuating the influenza 
virus in different population groups. A review of studies conducted on influenza 
immunization surveillance, and the forms used, as well as how to effectively evaluate a 
surveillance system, will follow .. 
Influenza 
Influenza A and B are the two main types of influenza viruses. Influenza A 
viruses, which undergo antigenic changes every year, are the most common cause of 
epidemic influenza (Health Canada, 2000b ). Influenza B viruses are more localized and 
may be restricted to one country or region in any given year (Health Canada, 2000b ). 
The influenza virus is a complex and dynamic virus. Influenza A viruses are 
classified into subtypes based on their hemagglutinin (H) and neuraminidase (N) 
antigens. Antibodies to these antigens, particularly to H antigen, can protect an individual 
from a virus carrying the same antigen. · During inter-pandemic periods, minor H antigen 
changes or "drift" are common. It is this antigenic variation from one influenza virus 
subtype to another that is responsible for continued outbreaks of influenza and that 
necessitates annual reformulation and administration of the influenza vaccine (Health 
Canada 2002). The antigens of influenza B viruses are much more stable than those of 
influenza A viruses and, although antigenic variation does occur, it is less frequent. The 
influenza virus may also undergo a major antigenic change or "shift" with different H 
and often a different N antigen from strains circulating previously (Health Canada, 
2002). This may result in pandemic influenza, meaning worldwide epidemic. 
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Influenza A and B are viruses that exist worldwide. The occurrence of influenza 
is not bound to seasons, and can occur all year round especially in tropical climates. In 
temperate zones, influenza is predominately a winter disease. In Canada, there may be 
outbreaks of influenza anytime during the fall and winter with definite outbreaks being 
common from November or December through April and May. According to Health 
Canada (2000b) there is no specific reason identified as to why influenza is 
predominately a winter disease. However, it is likely that the transmission of the virus is 
facilitated by people congregating indoors more during the winter, or drier indoor air 
which may help the virus survive longer. This also may be seen in the tropical zones of 
the world where the incidence of influenza is increased during the monsoons or rainy 
season whicl). may generate indoor crowding (Kilbourne, 1987). 
Impact of Influenza 
Influenza is an acute disease of the respiratory tract that typically has a sudden 
onset with headache, chills, and cough followed by fever, loss of appetite, muscle aches, 
and extreme fatigue (Chin, 2000). Most people recover completely from influenza 
within one to two weeks, however, severe complications can occur particularly in 
children, elderly people, and individuals with chronic conditions such as cardiac and 
pulmonary conditions. 
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Several studies have examined the relationship between the presence of 
circulating influenza virus and hospital admissions of individuals over age 65 years. 
Upshur, Knight, and Goel (1999) conducted a time series analysis from 1988 to 1993 to 
determine the relationship between influenza virus and hospital admissions of the elderly 
in Ontario, for pneumonia, chronic lung disease, and congestive heart failure. To perform 
the time series analysis, auto regressive integrated moving average transfer function 
models were used. These models were compared with simple cross correlations by using 
Pearson's product moment correlation. The results showed a statistically significant 
correlation between the presence of influenza virus and admissions of the elderly for 
pneumonia in all five years of the study. 
The study by Upshur et al. ( 1999) was subject to several limitations. The data 
used was administrative data collected by a records clerk when the patient was 
discharged. This data was not collected specifically for research purposes, therefore, the 
applicability of the data may be questioned. Another limitation of the database was the 
chance of multiple re-admissions which would increase the numerator and, therefore, 
bias the rates to overestimate the impact of influenza. There was also a possibility of 
misclassification of the ·diagnosis because up to 15 diagnostic codes may have been 
entered on any one patient. This could have caused confusion around the diagnosis most 
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responsible for the admission. 
Another study conducted by the Manitoba Centre for Health Policy and 
Information (2001) determined hospital influenza pressure periods each year from 1995- . 
1999. The weekly average number of hospital emergency room visits, visits to doctors, 
and drug prescriptions for influenza related illness were calculated. For the 1998-1999 
season, ambulatory visits for influenza like illness went from 7,821 per week in the non-
influenza period to 10,984 visits per week in the influenza period, which showed a 40% 
increase. At the Health Sciences and St. Boniface hospitals in Winnipeg, emergency 
room visits for influenza like illness went from 176 to 282 visits p~r week, showing an 
increase of 60% during the influenza period. The nlJ.mber of antibiotics prescribed per 
week increased 40% when the influenza virus was circulating. By examining these 
indicators, it was also found that more than half(54%) ofthe patients admitted to 
hospital for influenza like illness were aged 65 years and older. 
Two recent studies showed high influenza associated morbidity in healthy young 
children. Neuzil, Mellen, Wright, Mitchel, and Griffin (2000) showed that the rate of 
hospitalizations associated with influenza in infants younger than six months was similar 
to that of adults at high risk of influenza (1 04 excess cases per 10,000). Izurieta, 
Thompson and Kramarz (2000) studied hospitalization rates for acute respiratory disease 
among infants and young children younger than two years of age who did not have 
conditions that put them at high risk for complications of influenza. The hospitalization 
rates were 231 per 100,000 person-months for one site and 193 per 100,000 person-
months for the other site. These rates were 12 times higher than rates among older 
children, age 5 to 17 years, without high risk conditions. 
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The validity of the conclusions of the studies by Neuzil et al. (2000) and Izurieta 
et al. (2000) depends on the ability to distinguish the effect of the influenza virus from 
that of other infections that produce respiratory illness during the winter. Due to the 
expensive nature of testing patients for the presence of specific viruses, both studies used 
records of respiratory illnesses in hospitals and clinics for the defined population. Data 
obtained from viral surveillance systems were used to defme the timing of the influenza 
epidemics. This information was then used to assess the burden of influenza virus 
infection in various populations. Both studies tried to separate influenza virus from other 
viruses that are prevalent during the winter months. According to Gruber (1998) in most 
years even when the influenza virus is circulating, more children are hospitalized with 
respiratory syncytial virus (RSV) than with influenza. Because Izurieta et al. used 
hospital and clinic records as a way to distinguish respiratory virus infections from 
influenza, rather than testing the patients, this method may not have been a very effective 
one. Izurieta et al. defined periods when influenza predominated as all periods of two or 
more weeks in which at least 5% of the total number of influenza virus isolates and less 
than 5% positive tests for RSV were seen. If there were any periods where the actual 
number of RSV infections in a given age group was large in relation to the number of 
influenza infections, influenza might not have been dominant during some of those 
periods. Also, the comparisons were done in the summer and parts of the winter without 
known RSV activity, so the potential effects of undetected RSV remains a problem. 
These studies introduce uncertainty about whether influenza is responsible for all, or 
even most of the excess morbidity that is attributed to it, but the overall evidence does 
suggest that influenza is indeed a problem. 
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In Canada, the age standardized rate for hospitalizations for those 65 years of age 
and older due to influenza and pneumonia in the year of 1997-1998 was 1241 per 
100,000 population (Canadian Institute for Health Information, 1999). In Newfoundland 
for the year of 1997-1998, the age standardized rate for hospitalization was 1319 per 
100,000 population. 
The influenza virus does not only have an impact on increasing hospitalization 
rates but it is also associated with an increase in mortality. Influenza and pneumonia 
together are the sixth leading cause of death in Canada (Statistics Canada, 1997). The 
most recent calculated age standardized mortality rate due to pneumonia and influenza 
was in 1997 which showed a rate of24.0 per 100,000 (95% CI: 23.0-23.6) (Statistics 
Canada, 1997). It is important to note that this mortality rate does not separate influenza 
and pneumonia, and it does not separate cases of pneumonia that are secondary to 
influenza from other cases of pneumonia. The age standardized mortality rate due to 
influenza and pneumonia has been consistent over the previous four years. In 1993, the 
age standardized mortality rate for influenza and pneumonia was the same as it was in 
1997. In Newfoundland, the age standardized mortality rate for influenza and pneumonia 
in 1996 was 21.2 per 100,000 (95% CI:18.9- 23.5) (Statistics Canada, 1996). 
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While cancerhas the highest age standardized mortality rate of 181.5 per 100,000 
population, influenza and pneumonia have a higher age standardized mortality rate than 
diabetes which has an age standardized mortality rate of 17.4 per 100,000 population. 
Influenza and pneumonia also have a higher age standardized mortality rate than eight of 
the other selected leading causes of death which include: hereditary and degenerative 
diseases of central nervous system, suicide, nephritis, chronic liver disease, psychiatric 
disorders and HIV infection (Statistics Canada, 1997). 
The crude mortality rate in Canada for the year of 1997 from influenza and 
complications as a result ofthe influenza virus is 2.0 per 100,000 population. This can 
be calculated with Canada having a midyear population in 1997 of29,987,200 and a total 
of 608 influenza related deaths (Statistics Canada, 1997). With such a small crude 
mortality rate it can. be seen that deaths due to influenza are not the main reason why 
influenza is being addressed at the population level. 
Influenza is also of concern because it has an impact on health care expenditures. 
Health Canada (1998) determined the economic burden of illnesses in Canada. 
Influenza and pneumonia accounted for 386.1 million dollars of health care expenditures 
in Canada for 1998. When comparing the economic burden of influenza and pneumonia 
to other illnesses, breast cancer accounted for 84.8 million dollars, lung cancer for 227.5 
million dollars, and diabetes for 203.5 million dollars of the health care expenditures in 
1998. Thus influenza and pneumonia had the greatest economic impact. 
The influenza virus also has an effect on school and work absenteeism. Neuzil, 
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Hohlbein, and Zhu (2002) conducted a one year prospective study to quantify the effect 
of the influenza season on illness episodes, school absenteeism, medication use, parental 
absenteeism from work, and the occurrence of secondary illness in families among a 
cohort of children enrolled in an elementary school during the 2000-2001 influenza 
season. Of the 428 families with 611 children enrolled in the school, 216 families with 
313 children chose to participate in the study. The parent or guardian of a child 
participating in the study was sent a survey when their child was absent from school. This 
survey was sent to parents to determine the reason why the child was absent. The results 
of the study showed that during the influenza season the number of illness episodes were 
1.5 times more likely, school absenteeism was 1. 7 times more likely, and parental work 
absenteeism was 1.6 times more likely to occur. In addition, the number of household 
members ill in three days after the child was absent from school was 2.2 times more 
during the influenza season. 
The results of this study by Neuzil et al. (2002) were based on the surveys they 
received and not on laboratory or clinical evaluation. It was assumed that non-influenza 
illnesses occurred equally during the influenza and non-influenza winter season, 
therefore, any excess illness during the influenza season was attributable to influenza 
infection. Influenza infection actually may not have been the child's diagnosis which 
may have altered the results. The rates of parental absenteeism could have been higher 
because the rates presented in this study were based solely on missing work to care for a 
sick child. These rates did not include work that the parent may have missed if the child 
14 
transmitted influenza to the parent. 
The discussion of influenza's impact on society would not be complete without 
some mention of influenza pandemics. Pandemic influenza, meaning worldwide 
epidemic, is usually associated with a major antigenic change or "shift" and the rapid 
global spread of influenza A virus with H and often a different N antigen from strains 
circulating previously (Health Canada, 2002). Due to the fact that the virus undergoes an 
antigenic shift, everyone is susceptible to infection and will be at greater risk of 
developing severe complications due to influenza infection (Kilbourne, 1987). The 
vaccine takes time to be produced to protect against this particular strain and is therefore 
not immediately available to protect against the new strain of influenza. 
In the past century there have been three pandemics. The influenza pandemic of 
1918, known as the "Spanish flu,"was the most deadly pandemic in history, killing 20 
million people, primarily young adults (Kilbourne, 1987). Although mortality rates 
associated with more recent pandemics of 1957, known as the "Asian flu", and of 1968, 
known as the "Hong Kong flu,"were reduced in part by antibiotic therapy for secondal)' 
bacterial infections and more aggressive supportive care, both were associated with high 
rates of morbidity and social disruption (Kilbourne, 1987). The CDC (200la) predicts 
that the next pandemic will infect up to 200 million people in the US alone. Of those 200 
million people affected, 88,000 to 300,000 persons will die. Depending on the virulence 
and penetrance of infection, pandemic influenza could result in as many as 51 ,000 deaths 
in Canada (Tam, 1999). In 1997, the number of influenza related deaths in Canada was 
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calculated to be 608. When comparing the proj.ected 51,000 deaths due to influenza and 
related complications that could occur during the next pandemic to the 608 deaths that 
were seen in 1997, the potential impact that future influenza pandemics may have on 
morbidity and mortality can be easily seen. 
The warning period preceding spread of the pandemic strain in Canada is likely to 
be relatively short, therefore, vaccine will have to be distributed and administered as 
rapidly as possible. It is important to have mechanisms in place, far in advance of the 
pandemic, so that vaccine supplies can be efficiently distributed and high rates of 
compliance achieved. There will be no time available to change attitudes and convince 
individuals to receive the vaccine. Therefore, during the inter-pandemic period, it is 
important to achieve high influenza immunization rates so individuals will be used to 
receiving the vaccine and will therefore be willing to receive it during a pandemic. 
In summary, although it is difficult to completely separate influenza from other 
respiratory infections, the influenza virus does increase morbidity and mortality, health 
care expenditures and absenteeism during the influenza season. Therefore, prevention of 
influenza and its complications is warranted. 
Effectiveness of Influenza Immunization 
The influenza vaccine is recognized to be the single most effective way of 
preventing influenza for those at high risk of serious illness or death (Health Canada, 
2000a). The influenza vaccines presently used in Canada are inactivated suspensions of 
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one or more strains of virus grown in hens' eggs with thimersol as a preservative and 
possibly gelatin as a stabilizer (Health Canada, 1998). The virus strains chosen for 
inclusion in influenza vaccine are reviewed annually to ensure they include antigens that 
are expected to provide the best protection against the strains anticipated to be circulating 
during the following winter. Protection of the vaccine usually begins two weeks after 
injection and may last for six months or longer. 
Numerous studies have demonstrated the effectiveness of influenza 
immunization. Several retrospective studies suggest that vaccination of elderly people 
results in a decrease in complication rate by 70%, and mortality by 87% (Barker & 
Mullooly, 1980; Barker & Mullooly,1981; & Barker & Mullooly, 1982). Govaert, 
Sprenger, Dianant, Aretz, Masurel, and Knotterus (1994) conducted a prospective 
randomized double blind placebo-controlled trial to determine the efficacy of influenza 
vaccine in elderly individuals. There were a total of 1838 participants in the study aged 
60 years or older and both randomly assigned groups were similar with respect to age, 
sex, risk factors, previous vaccination in past two years, and protective antibody titre 
before vaccination. The placebo group (n=911) received an intramuscular placebo 
containing physiological saline solution and the experimental group (n=927) received the 
influenza vaccine composed in accordance with the advice of the World Health 
Organization. The main outcome measures were: the identification of influenza like 
illness up to five months after vaccination; self reported influenza through postal 
questionnaires at ten weeks and five months after vaccination, and serological influenza 
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(which was defined as a serum sample with a four fold increase of antibody titre between 
three weeks and five months after vaccination). The vaccine group was noted to have a 
lower incidence of serological influenza (4%), than the placebo group (9%) (RR: .5; 95% 
CI: .35 to .61 ). The incidence of clinical influenza was also lower in the vaccine group 
(2%), in comparison to 3% in the placebo group (RR: .53; 95% CI: .39 to .73). The effect 
was strongest for the combination of both serological and clinical influenza (RR: .42; 
95% CI: .23 to .74). This study shows that influenza vaccination may halve the incidence 
of serological and clinical influenza in the elderly. 
Influenza infection is known to be more severe in patients with chronic renal 
diseases, therefore, it is recommended that these patients receive annual influenza 
immunization (CDC, 1998). However, there are some discrepancies between the results 
of studies on immune response to influenza vaccination in patients with renal disease. 
Some of these studies confirmed a good seroresponse in this group of patients, while 
others indicated significantly lower antibody levels compared with healthy people 
(Descamps-Latscha & Chatenoud, 1996; Steele, 1994). Because of mild or severe 
immunological disorders observed in patients with renal disorders, a poorer immune 
response would normally be expected in this group (De scamps-Latscha & Chatenoud, 
1996). However, 22 children with nephrotic syndrome achieved a four- fold titre 
increase which ranged, depending on the vaccine strain, from 68% to 86% after 
influenza vaccination. This was comparable to the response rates seen in healthy people 
(Brydak, Rajkowski & Machala, 1998). 
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Furth, Neu, and McColley (1995) conducted a study on children with end stage 
renal disease requiring dialysis and on patients after renal transplantation. This study 
showed that these patients benefited from vaccination against influenza, regardless of 
the severity of renal disease. This study also calculated a protection rate, defined as the 
proportion of subjects exceeding the threshold titre of 100 after vaccination. Protection 
rates depending on the vaccine strain, ranged from 66% to 80% in children with chronic 
renal failure, 80% to 100% in dialysed patients, and 71% to 86% in the healthy group 
four weeks after vaccination. Convincing results were also obtained by Grekas, 
Alivanis, and Kotzadamis (1992) where the percentage of 19 patients on haemodialysis 
(age 20 to 60 years) showing at least a four- fold titre increase which ranged, depending 
on the vaccine strain, from 31.5% to 47% one month after vaccination and 87.5% to 
1 00% two months after vaccination. 
Individuals with diabetes have been identified by the National Advisory 
Committee on Immunization as a group of individuals at increased risk for developing 
complications due to influenza infection. Diepersloot, Bouter, and Beyer (1987) 
conducted a study on 159 patients with type 1 or type 2 diabetes who were vaccinated 
with whole virus influenza vaccine. The humoral immune response was lower in 
patients with diabetes compared with healthy vaccinated controls, however, the 
difference was not statistically significant between these two groups. The protection 
rates measured after vaccination ranged, depending on the vaccine strain, from 57% to 
85% in the patients with diabetes and 50% to 90% in the control groups. The protection 
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rates were between 44% and 78% in patients with type 1 diabetes and between 65% and 
87% in patients with type 2, while in the control groups these values were from 67 to 
100%. 
Influenza vaccine is also effective in reducing mortality during an epidemic, as 
can be seen by the study conducted by Ahmed, Nicholson and Nguyen-Van-Tam 
(1995). Their case control study assessed the effectiveness of influenza vaccine in 
reducing mortality during an epidemic. Subjects were 16 years of age or older who died 
between November 4, 1989 and February 23, 1990. General practitioners' reports were 
reviewed for 315 patients who had died of influenza during an epidemic and 777 
controls who died from a cause other than influenza a year after the epidemic. Cases 
and controls were matched for age, sex, existence of chronic illness, and area of 
residence. Conditional logistic regression analysis for matched case-control studies 
showed that influenza vaccination reduced mortality by 41% (95% CI: 13 to 60) for all 
subjects. There was no statistically significant difference in the effect of vaccine 
between subjects who lived in institutions and in the community (p=0.16), or between 
subjects with high risk medical conditions and those without (p=0.76). 
Based on studies among young healthy volunteers, influenza vaccination appears 
to be 40% to 70% protective (McDonald & Andrews, 1955; Members of the 
Commission on Influenza, 1953 and Committee on Clinical Trials of Influenza Vaccine, 
1953). Although vaccination in healthy adults is protective, the influenza immunization 
program for this population has been scrutinized in terms of its cost effectiveness. 
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Nichol (200 1) assessed the economic implications of a strategy for annual influenza 
vaccination ofhealthy adults age 18 to 64 years. The cost benefit analysis included 
direct and indirect costs associated with vaccination, as well as costs saved by 
vaccination. Clinical and economic variable estimates were derived primarily from 
published literature. Monte Carlo simulation was used to calculate the mean net costs or 
savings, along with the 95% probability interval, and sensitivity analyses explored the 
sensitivity of the cost model to different values of the input variables. The study showed 
an average annual savings of$13.66 per person vaccinated. Seventy eight percent of 
costs savings were costs related to lost work productivity. In Newfoundland, there were 
86,000 doses of influenza vaccine distributed last year. Assuming that the annual 
savings per person vaccinated were the same in Newfoundland as those in the study by 
Nichol and the number of influenza vaccine doses distributed (86,000) were equal to the 
number administered, there would be a potential cost savings of $1,174,760 per 
population vaccinated. This cost savings calculation may be a gros overestimation 
because a large portion of the (86,000) doses of vaccine may have been administered to 
elderly individuals who do not work, while Nichol's calculation was based on lost 
productivity. The findings of the study by Nichol are valid only if the underlying 
assumptions and values used for the individual variables included in the model are valid. 
The model assumed that the persons targeted for vaccination were full time, year round 
workers, therefore the fmdings may not apply to part time, seasonal workers. There 
were no studies found that were conducted on the cost savings for older individuals. 
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Effectiveness of Influenza Immunization Campaigns 
Influenza immunization programs are presently not reaching the target goal of 
immunizing 90% of those who should receive the vaccine. Because influenza 
immunization is known to significantly decrease rates of influenza, it is important to 
understand why individuals are not receiving influenza vaccine and to determine ways 
to promote influenza vaccination. 
Y assi, Murdazk, Cheang, Tran and Aoki ( 1994) used a self-administered 
questionnaire to determine the knowl~dge, attitude, and behaviour regarding influenza 
vaccine of 519 health workers from high risk hospital areas. There were 948 
questionnaires sent with a response rate of 55%. There was no statistically significant 
differences noted between the demographic profiles of responders and non-responders. 
The knowledge of the health care workers regarding influenza vaccine was assessed: 
50% knew who should receive the vaccine, 56% knew the influenza vaccine was 
important for health care workers as they could easily spread it to patients. Registered 
nurses had more knowledge regarding influenza vaccine than other occupations. A 
positive correlation was seen between greater knowledge of vaccine and willingness to 
recommend it to others. However, there was no correlation between knowledge and 
willingness to receive vaccine, as nurses were noted to have the most knowledge but 
highest refusal rate of80.5%. Health care professionals in this study were most willing 
to receive vaccine under certain conditions: if they heard about the vaccine from their 
private physicians; if the vaccine was offered to them; and if they had the vaccine in the 
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past and experienced only a few post-vaccine side effects. This study suggests that 
knowledge does not change behaviour, however, strong promotional efforts and easy on-
site access may help increase influenza immunization rates. 
The study by Yassi et al. (1994) showed that there was no correlation between 
knowledge and willingness to receive influenza immunization. Well structured 
influenza immunization programs have been used as a method to increase vaccine 
uptake. A cross sectional survey conducted by McArthur, Simor, Campbell, and 
McGeer (1999) consisted of mailing 1,520 questionnaires to long term care facilities for 
the elderly in Canada. They looked at which vaccination programs were associated with 
high resident vaccination rates. The overall survey response rate was 1,270 (84%), of 
which the mean overall vaccination rate was 79%. By using multi-variable analysis, 
increased vaccination rates were associated with several variables; vaccine being offered 
to all residents rather than some, having a single non-physician staff member organize 
the program, and obtaining consent for immunization upon admission rather than 
annually. Although each component was associated with a modest increase in rates, the 
mean vaccination rate was 40% in facilities with one of the factors previously 
mentioned, and 91% in those with all of the above components. 
McAuther et al. (1999) found that well organized influenza vaccination 
programs increase the influenza vaccination rates of residents in Canadian long term 
care facilities. In addition to well structured influenza immunization programs, strong 
influenza immunization promotional campaigns can also increase influenza 
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immunization rates. Ontario's universal immunization program, which was initiated in 
the 2000-2001 influenza season, is an example of an immunization program that used a 
strong promotional campaign. This program consisted of publicly funded influenza 
vaccine for all individuals as well as strategies to increase vaccination rates and decrease 
rates of influenza. According to Ontario's Ministry ofHealth and Long Term Care 
(200 1) the promotional campaigns included use of communication products such as 
letters to the health care community, public and businesses. There were community 
outreach activities such as local media events, public health unit driven events and 
clinics, a toll free number with information about the program, targeted information kits 
for public health units, doctors, hospitals, and employers, and website pages. The 
awareness of the program increased by 41% from July to December 2000, and at the end 
of the campaign only 9% of individuals were not able to identify a specific component 
of the program. There were 7.9 million doses of vaccine distributed for the universal 
influenza program. 
As a way to begin to evaluate Ontario's universal influenza immunization 
program one can compare the number of laboratory confirmed cases of influenza in 
Ontario in the 1999-2000 to the 2000-2001 season. In the 1999-2000 season up to and 
including the week ending April14, 2000 there were 2,889 confirmed cases of 
influenza. In the year of 2000-2001, Ontario's laboratory confirmed cases of influenza 
decreased to 840 (Ontario's Ministry of Health and Long Term Care, 2001). The 
number of influenza outbreaks in care facilities had also decreased from 341 in 1999-
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2000 to 7 in 2000-2001. Despite the fact that there is very little information available on 
the nllinber of individuals immunized during the universal program, there was a 
significant decline in the number of influenza cases reported. This decrease may be due 
to the universal immunization program which had been initiated for that influenza 
season. 
Reports of confirmed influenza were lower all across Canada in the 2000-2001 
season (Canadian Communicable Disease Report, 2001). Therefore, it is difficult to 
determine if the rates of influenza have actually declined by looking at differences in the 
laboratory confirmed cases from year to year. Monitoring of laboratory confirmed cases 
of influenza is not intended to count the actual number of cases during the particular 
influenza season, but rather to determine where there is influenza activity. Therefore the 
decrease in the number of cases presented by the Ontario's Ministry of Health and Long 
Term care should be interpreted with caution, and a more effective method of 
determining influenza rates and accounting for the influenza vaccine distributed should 
be put in place. 
The Need For Influenza Immunization Surveillance 
Studies have shown that influenza immunization is effective in preventing 
influenza for those at high risk of serious illness. Every year, provincial community 
health boards distribute vaccine to physicians' clinics and public health offices. The 
vaccine distributed is a crude measure that is not synonymous with vaccine actually 
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gtven. "The goal of influenza immunization programs should be 100% coverage of 
vaccine eligible groups to prevent serious morbidity and mortality due to influenza in 
both interpandemic and pandemic periods" (Health Canada, 1993, p.l41). Realistically, 
.influenza vaccination programs should aim to vaccinate at least 90% of eligible 
recipients (Health Canada, 2000a). It is important for health care providers to develop 
influenza immunization promotion campaigns, since annual fall campaigns have been 
helpful in increasing influenza vaccination coverage rates (Health Canada, 1993). 
The proportion ofvaccine eligible groups receiving influenza vaccination should 
be determined in order to decide who the health promotion campaign should target. To 
calculate the percentage of vaccine eligible groups that receive influenza vaccine, the 
number of individuals vaccinated (numerator) is required, as well as the number of 
individuals eligible (denominator). Presently, in Newfoundland and Labrador, there are 
no surveillance systems in place in community settings to determine if vaccine eligible 
individuals who reside in the community are actually receiving annual influenza 
vaccine. Without such a system it is difficult to determine the number of influenza 
immunizations administered each year and if influenza vaccination programs are 
reaching those who are considered to be the target group. 
Methods of Influenza Immunization Surveillance in the Community 
There is more documented literature about influenza immunization surveillance 
for institutionalized individuals than in community settings. Russell (2001) conducted a 
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study to determine influenza vaccination rates in Alberta's long term care facilities. An 
anonymous survey was sent to Alberta nursing homes and auxiliary hospitals in the 
spring of 1999. Of the 160 facilities surveyed, 136 responded. Of those who 
responded, 85 provided data on staff vaccination rates and 118 provided data on resident 
vaccination rates. For institutions reporting this information, the median proportion of 
staff vaccinated was 29.9% and the median proportion of residents vaccinated was 91%. 
Vaccination rates were easily determined for residents since the institutions had 
structured influenza vaccination programs and the programs were the responsibility of 
one department. Influenza vaccination records could therefore be retrieved without 
difficulty from residents' files. Influenza immunization surveillance is more difficult to 
track in the community since there are many professionals in different locations 
providing influenza vaccination and all community based health care providers have 
different recording systems. 
Through searching Medline and CINAHL data bases there were only a few 
studies found which looked at community based influenza immunization surveillance. 
Several of the surveillance methods which have been tried consisted of denominator 
based tracking systems, random digit dialling surveys and sending out influenza 
immunization surveillance forms to health care providers who administer influenza 
vaccine. 
Buffington, Bell, and Laforce ( 1991) conducted a study to measure the impact of 
a denominator based tracking system on influenza immunization rates. These 
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researchers looked at 13 practices with 45 private practice physicians in the Rochester, 
New York area. All patients 65 years of age and older who were seen in participating 
physicians' practices within two years preceding the study were considered as the target 
population for the study. There were two intervention groups and one control group in 
this study. In the first intervention group, the target population for each physician 
(which was the denominator) was entered on a specifically designed poster. Physicians 
were asked to record all immunizations given to the target population and on a weekly 
basis tabulate a cumulative total. From this, the physicians were asked to calculate the 
proportion of the target population vaccinated and graph the percentage on the poster. 
The second intervention group did the same as the first, however, they also sent postcard 
reminders to all their patients aged 65 years and older. The control group did not use the 
poster, nor did they send out reminders, they simply determined the number of patients 
who were 65 years and over that had received vaccine by reviewing computer generated 
billing codes at the end of the study season. 
The results of the study by Buffington et al. (1991) showed that the control 
group immunized 50% (2,405 of 4, 772) of its target population, while the poster and 
poster/postcard groups immunized 66% (1,420 of2,149) and 67% (2,427 of3,604) 
respectively. The difference in the proportions immunized by all three groups was 
statistically significant (p<0.001). The goal of this study was not to determine 
denominator data for the purpose of influenza immunization surveillance but rather to 
use denominator tracking methods such as the poster and postcard reminders to increase 
28 
influenza immunization rates in the identified target population. A denominator based 
tracking system could be used as a method of influenza immunization surveillance, 
however, it may not be a practical way to collect data on all the target groups who 
receive influenza immunization. 
Squires, Macey, and Tam (2001) of the Division ofRespiratory Diseases of 
Health Canada, commissioned a polling company to conduct a random-digit dialling 
telephone survey to estimate influenza and pneumococcal vaccine coverage rates for the 
2000-2001 influenza season. Residents from all provinces and territories were included, 
and provincial and territorial samples were weighted based on their proportion of the 
Canadian population. The survey took place in January/February 2001, and 3501 
non-institutionalized Canadian residents 18 years of age and older were surveyed. The 
results ofthe survey showed that 38.4% (95% CI: 35.1%- 41.8%) of individuals with 
high risk medical problems received influenza vaccine in the 2000-2001 season. In 
comparison, 69.1% (95% CI: 65.0%- 73.2%) of individuals over 65 years of age 
received influenza vaccine. Half, 54.8% (95% CI: 49.0%-60.6%), of health care 
workers surveyed received vaccine. 
This study shows that there is still a significant proportion of individuals with 
high risk conditions and health care workers who do not receive influenza vaccine. 
Despite the fact that this study shows the proportion of individuals age 65 years and 
older that receive influenza vaccine to be 69.1%, there is still work needed to increase 
vaccination rates since the aim of influenza immunization programs is to vaccinate 90% 
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of eligible recipients (Health Canada, 2000a). 
The strength of the study by Squires et al. (200 1) is the large sample size and the 
ability to get denominator data and generalize the results because they used random 
sampling. However, random-digit dialling telephone surveys are not a practical way to 
track influenza immunization in the community. This method is a very time intensive 
way to perform surveillance and it is not a mechanism that could be used every year to 
receive influenza immunization data, particularly in small regions. 
Macdonald, Roberecki, and Conway (1996) examined influenza vaccine 
distribution and the population immunized by primary care physicians, public health 
nurses, and institutions, in the Rural Interlake region ofManitoba. In August of 1994, 
the Medical Officer of Health (MOH) asked each provider to estimate the influenza 
vaccine doses required for the upcoming season. The number of doses requested were 
then sent to the health care professional with a survey form to record the doses as given 
according to the target risk group. The completed form was to be returned to the MOH 
by January 1995. The overall survey response was 82.7%. The four public health 
nursing offices and 16 institutions had a response of 100% and there was a response of 
71.9% for the 32 participating physician offices. Of the 8,960 doses distributed, it was 
determined that 7,260 (77.7%) doses were actually accounted for and given. Two 
thirds (64.7%) ofthe vaccine accounted for was given to individuals age 65 years and 
older. 
The use of an influenza immunization surveillance form in the study by 
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Macdonald et al. (1996) was a successful mechanism to collect influenza immunization 
information as they were able to account for 77.7% ofthe vaccine distributed. The 
forms were returned to the MOH when completed. This may be a reason for their high 
response rate as participants may have seen it as a requirement. There was no copy 
provided of the form sent to health care providers in the article published by Macdonald 
et al. which outlined the study. The Manitoba Health department was contacted to 
determine if a copy of the form used in the study by Macdonald et al could be obtained. 
Several Medical Officers of Health were contacted but the form used in this study was 
not located. Therefore it was difficult to determine how the information was collected 
and what the form looked like. There was also no reason provided as to why 28.1% of 
physicians failed to respond to the survey. In addition, the researcher did not receive 
opinions from the respondents on the surveillance form and the form was not evaluated. 
Manitoba's Communicable Disease Control Unit also developed an influenza 
immunization surveillance form to capture case by case information on clients receiving 
influenza vaccinations in the 1999-2000 season. Prior to this, no formal tracking 
mechanism was in place to capture adult immunization data. Vaccine coverage had 
been estimated by the number of doses distributed and population estimates obtained 
from national studies such as population health surveys (Manitoba Health, 2000). The 
form consisted of a tally style form which collected the patients' names, as well as their 
date of birth, date of vaccination, gender, and whether they were over 65 years, or over 
65 years with a chronic illness, health care staff, or "other" . In total, 18,279 records 
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representing data on individual patients were entered for the 1999-2000 season. The 
study did not reveal the number of doses distributed or the proportion of doses that were 
tracked. However, in the previous season there were 170,000 doses of influenza vaccine 
distributed. A proportion of the 18,279 records received were not from the actual forms 
but were obtained from physician claim data. The study failed to separate the 
proportion of data from the forms or physicians' claims. The forms were not sent to fee 
for service physicians, as they were in the study by Macdonald et al. (1996). It was felt 
that these physicians would not complete the forms (personal communication, Jackie 
Habing, Influenza Prevention Coordinator Manitoba Health, July 4, 2001). 
If a similar number of influenza vaccine doses was distributed in the 1999-2000 
season, the surveillance system only accounted for 10% of the doses administered. 
This may be due to the fact that the Communicable Disease Control unit in Manitoba 
did not have a formal mechanism in place to track receipt of surveillance 
forms and the responsibility to collect the information and forward the data on to the 
Communicable Disease Control unit was the responsibility of each health provider. 
Under reporting was known to have occurred because forms were received after the 
surveillance initiative was over. Surveillance was also initiated late in the campaign and 
several influenza vaccination clinics had already taken place before the surveillance 
program was endorsed by the Regional Health Authority. 
In summary, the random digit dialling survey used by Squires et al. (200 1) was 
not a practical way to collect influenza immunization surveillance data. Buffington et 
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al. (1991) used a denominator based tracking system as a way to increase influenza 
immunization rates. This system could also be used to collect influenza immunization 
surveillance data, however, it would not be a practical way to collect data on all the 
target groups who should receive the influenza vaccine. The influenza immunization 
surveillance forms used in the study by Macdonald et al. (1996) and those used by 
Manitoba Health (2000) appear to be a more practical method of conducting influenza 
immunization surveillance in a community setting. 
Nurses and Influenza Immunization Surveillance 
Public health nurses have always played an essential role in immunization 
surveillance since they provide and document childhood immunizations and use this 
information to help plan and evaluate immunization programs (Zahner,1999). In the 
Eastern Region of Health and Community Services, in Newfoundland and Labrador, 
community health nurses administered over 80% of childhood vaccinations (personal 
communication, Patricia Heath, Communicable Disease Control Coordinator Eastern 
Region, November 24, 2002). There is a structured mechanism in place where 
community health nurses send their childhood immunization surveillance forms to the 
communicable disease unit for data entry. This process takes place yearly and has 
existed for many years. The nurses are sent yearly reminders to submit their forms and 
there is a 100% response rate to childhood immunization surveillance. Patricia Heath 
(personal communication, November 24, 2002) attributes this success to the fact that 
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nurses have administered the majority of childhood immunizations and are familiar with 
documenting and submitting this information for data entry. There is one person 
responsible for coordinating the submission of the forms which makes it a very 
structured mechanism. In addition, all the community health nurses are employees of 
the same Health and Community Services Board. This helps because all community 
health nurses follow the same guidelines and the expectation to complete surveillance 
forms is the same for everyone. The conmmnity health nurses are aware of the 
importance of collecting immunization statistics and they aim to have a 100% childhood 
immunization rate. 
There were only a few studies found regarding nurses and their involvement with 
surveillance systems. The study by Macdonald et al. (1996), which was previously 
described, showed that the public health nursing offices' response to the influenza 
immunization surveillance initiative was 100%, whereas the physicians' response was 
only 71.9%. The study also found that public health nursing offices had a higher 
proportion, 86.9%, of doses administered to doses distributed than did physicians, 
75.4%. This study showed that all the nurses who were sent influenza vaccine 
participated and had less wastage of the vaccine they had been distributed. 
Nurses were involved with completing the influenza immunization surveillance 
forms developed and sent out by the Communicable Disease Control Unit in Manitoba 
in 1999-2000. Jackie Habing (personal communication, Influenza Prevention 
Coordinator Manitoba Health, July, 4, 2001) stated that the Communicable Disease 
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Control Unit in Manitoba only sent their forms to nurses and salaried physicians. 
Despite the fact that fee for service physicians received influenza vaccine, they did not 
send fee for service physicians their influenza immunization surveillance forms because 
it was felt that they would not complete the forms, since they had difficulty receiving 
similar information from them in the past. 
Public health nurses play a significant role in immunization surveillance. They 
are responsible for a large percentage of childhood immunizations and have a structured 
mechanism in place to track these immunizations. The study by Macdonald et al. (1996) 
showed that nurses had a higher response rate with returning their surveillance forms 
and had a higher ratio of the number of doses administered to doses distributed. Public 
health nurses are familiar with carrying out immunization surveillance and therefore can 
be a great asset in collecting immunization data. 
Evaluating Surveillance Systems 
The evaluation of surveillance systems should promote the best use of public 
health resources by ensuring that only important problems are under surveillance and 
that surveillance systems operate efficiently (CDC, 2001). Most importantly, an 
evaluation should assess whether a system is serving a useful purpose while meeting the 
surveillance system's overall objectives. A surveillance system is useful if it contributes 
to the prevention and control of adverse health events, and if it increases awareness of 
the importance of controlling the occurrence of such an event (CDC, 2001 ). There are 
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seven attributes identified by the CDC (200 1) as important to consider when evaluating 
a surveillance system. The seven attributes which are necessary for an efficient and 
effective system are: adequate sensitivity, timeliness, representativeness, adequate 
positive predictive value, simplicity, acceptability, and flexibility. 
According to the CDC (2001), sensitivity is the measurement ofhow many cases 
are picked up by the surveillance system, showing that any missed cases could alter the 
results of the surveillance system. The positive predictive value is the probability that an 
identified case truly is a case. If a surveillance system has high positive predictive 
values it will help enable health officials to focus on productive activities. To increase 
the usefulness of a surveillance system, it is important to ensure the system is accepted 
by those who use it, that it is simple to use and that it provides the health care 
professional with flexibility. A representative surveillance system will better 
characterize the epidemiological characteristics of an event in a certain population. A 
lack of representativeness could affect the usability of the information produced. 
Timeliness reflects the speed or delay between steps in a surveillance system. 
Timeliness is a component that may not be important in some programs, but may be 
critical in others. 
Because surveillance systems vary widely in methodology, scope, and 
objectives, the criteria that are important to one system may be less important to another 
(CDC, 2001). Therefore, the success of a surveillance system may rely on an adequate 
balance of these attributes. As well, the strength of the evaluation depends on the ability 
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of the evaluator to assess these attributes with respect to the system's objectives. It is 
important for the evaluator to understand that all seven attributes will not be appropriate 
for all surveillance systems (CDC, 2001). 
The studies which were conducted and previously discussed on influenza 
immunization in the community did not report evaluating the surveillance systems used. 
This supports the need to increase research studies conducted in a community setting 
which evaluate an influenza immunization surveillance system. Without an evaluation 
component it is very difficult to determine if the surveillance system is serving a useful 
public health function while meeting the system's overall objectives. 
Summary 
Influenza has an impact on morbidity and mortality, hospitalization, health care 
costs and lost productivity and work time. Influenza vaccine is known to be effective, 
however, influenza vaccination rates are less than 90%. Immunization promotional 
campaigns help increase influenza immunization rates, but health care providers must 
know who is or is not receiving vaccine in the community so they will know to which 
groups campaigns should be targeted. 
To calculate the proportion of vaccine eligible groups that receive influenza 
vaccine, the number of individuals vaccinated (numerator) must be determined as well 
as the number of individuals eligible (denominator). Surveillance is a method of 
collecting numerator and denominator data. Some denominator data is readily available 
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through existing population health data. 
There were only a few influenza immunization surveillance methods in the 
community which have been reported in the literature. Buffington et al. (1991) found 
that when physicians used a poster to track the proportion of the target group vaccinated 
and sent out post card reminders to the target population it allowed them to track the 
proportion of the target group vaccinated. Physicians who used the poster and sent post 
card reminders also showed an increase in the amount of vaccine administered to the 
target population, compared to physicians in the control group who used computer 
generated billing codes at the end of the season to determine their target population. 
While this method was an ideal way to determine the proportion of target group 
vaccinated, it would not be practical because it would be very time consuming and it 
may be difficult to get the physicians' cooperation. Squires et al. (200 1) used random 
digit dialling as a way to identify the proportion of a variety of target groups vaccinated. 
This method is not a practical way to collect influenza immunization data since it is very 
time consuming and expensive. MacDonald et al. ( 1996) used surveillance forms and 
were able to account for 72.7% of the vaccine distributed, but there was no feedback 
from participants regarding the forms or details regarding identification of target groups. 
Communicable Disease Control unit in Manitoba (2000) used a tally form to collect 
influenza immunization surveillance data, however, it was unclear what proportion of 
the doses were accounted for using the surveillance form. This method of surveillance 
would be a practical method to try again. However, it would be important to add a 
feedback component to the system and to evaluate the system to determine it's 
effectiveness in collecting influenza immunization data. 
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In conclusion, there are gaps in the literature regarding the best form of influenza 
immunization surveillance. In order to clarifywho is receiving influenza vaccine and 
where to target influenza immunization campaigns, an influenza immunization 
surveillance system must be implemented and evaluated. The use of influenza 
immunization surveillance forms would be a practical way to collect surveillance data in 
comparison to the two other forms of surveillance which have been implemented in 
previous studies. The evaluation of the surveillance initiative will help determine if 
influenza immunization surveillance is an effective way to retrieve useful numerator 
data. 
CHAPTER3 
Methodology 
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This chapter presents the methods used to conduct this study. The initiative being 
evaluated, the instruments used, the data collection procedure, and data analysis are 
described. The ethical considerations are also discussed. 
Design of the Study and the Surveillance Initiative 
This descriptive, prospective study was designed to assess and compare the 
effectiveness of three influenza immunization surveillance forms in accounting for the 
influenza vaccine distributed to health care professionals practising in the community. 
Initially the study was designed to test two surveillance forms (tally form and individual 
form) but at the beginning of the 2001-2002 influenza season, the government of 
Newfoundland and Labrador developed and distributed a form (government form) to all 
health care professionals that received influenza vaccine. In the Eastern Region of 
Health and Community Services this form was sent to the health care professionals that 
refused to complete the individual or tally forms. Therefore, community health nurses 
and physicians in the eastern region of the province were provided with one of three 
influenza immunization surveillance forms, which were completed on each patient 
receiving influenza vaccine during the 2001-2002 season. The completed forms were 
returned to the Medical Officer of Health (MOH) at the end of the influenza 
immunization season. Once the forms were returned, health care professionals were 
contacted to provide feedback on the surveillance forms. 
Setting and Respondents 
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The study was conducted in the communities under the geographic boundaries of 
Health and Community Services Eastern, Newfoundland and Labrador. There are 
approximately 65 clinics/practices in this area of the province. These clinics consist of 
family physicians and community health nurses who administer influenza vaccine 
annually to individuals residing in the community. All practices were sent surveillance 
materials with their annual vaccine order. Those who returned completed surveillance 
forms were considered respondents in this study. 
Surveillance Forms 
There were three influenza immunization surveillance forms used. These were 
the tally form, found in appendix B, individual form, found in appendix C, and the 
government form, found in appendix D. The tally and the individual forms were 
designed for this study. These two surveillance forms contained the same information, 
however, each form had a different format. The tally form allowed the health care 
professional to document information on 12 patients per form, whereas health care 
professionals who completed the individual form completed one form per patient. Both 
forms contained the items of age, sex, reason for immunization, and date of 
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immunization. Health care professionals also had an opportunity to indicate on the tally 
form and individual form if the patient received the influenza vaccine in the previous 
year, or had received pneumococcal vaccine in the past. 
The third form was the government form which consisted of two columns, one to 
indicate if patients were over 65 years of age and the other to indicate if patients were . 
under 65 years of age. The health care professional was required to add up the number of 
patients who received vaccine and write the total numbers in each column after every 
clinic. No patient specific identifying information was recorded on any of the three 
surveillance forms. 
Data Collection Procedure: Immunization Surveillance 
The first step in data collection consisted of sending health care professionals a 
letter from the MOH, found in appendix E, explaining the influenza immunization 
surveillance initiative for the 2001-2002 season. This letter was sent with the influenza 
immunization order forms that are sent annually. Practices were stratified into two 
groups: one group consisted of practices with three or fewer health care professionals, 
and the other group consisted of practices with more than three health care professionals. 
By using random allocation, half of the practices in each stratum received the tally form 
and the other half received the individual form. A sample copy of the surveillance form 
and the letter from the MOH was sent out to each health care provider with the letter 
explaining the study, found in appendix F. Within the first week, after all forms and 
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information had been sent out, all health care professionals were contacted to determine 
if they had any questions about the study and if they were going to participate. Ifhealth 
care professionals stated or provided notification that they were not going to complete the 
tally or individual forms, they were sent the governmerzt form to complete. Health care 
professionals were not asked to provide an explanation as to why they refused to 
completed the forms used in this study. 
After the study explanation was sent out, along with a. copy of the surveillance 
form, health care professionals were sent copies of their surveillance forms with their 
vaccine order. Health care professionals were also sent a minimum of five appropriately 
addressed stamped envelopes to use to return completed forms. 
Completed influenza immunization surveillance forms were returned to the MOH 
every month. Every practice received a monthly reminder by fax to complete 
surveillance forms for each dose of vaccine given and to return completed forms. A final 
fax was sent at the end of the influenza season to remind health care professi~nals to 
return completed surveys and to return unused vaccine. 
As a final part of data collection, the communicable disease control nurses that 
work in the other Health and Community Services Boards in the province of 
Newfoundland and Labrador were contacted to determine how many government forms 
they had received from health care professionals, as well as how many doses of influenza 
vaccine they accounted for by using the government form. 
43 
Data Collection: Evaluation of Surveillance Forms 
The final stage of the data collection occurred at the end of the immunization 
season and when all potential surveillance forms were returned. Once the forms were 
returned, each health care professional was contacted to provide feedback. There was 
one questionnaire used for study respondents, found in appendix G, and a separate one 
for non-respondents, found in appendix H. The respondents' questionnaire consisted of a 
number of open ended questions. These questions were developed as a way to determine 
if the form of surveillance used was an effective way to account for all the influenza 
vaccine distributed and if the respondents felt that they would be willing to use the same 
surveillance forn1 in the future. This questionnaire also determined who completed the 
surveillance forms (office staff, physicians or nurses) and how the health care 
professionals felt about influenza immunization surveillance in general. 
The questionnaire for the non-respondents consisted of two open ended questions. 
This questionnaire gave non-respondents the opportunity to provide suggestions on ways 
to facilitate their participation in the future. In addition, the questionnaire determined 
how these health care professionals felt about influenza immunization surveillance. 
Data Analysis 
The data was entered into a database, then coded and "cleaned" prior to analysis. 
The Statistical Package for Social Sciences (SPSS) was used for statistical analysis. The 
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investigator performed all the data analysis. Descriptive statistics were used to 
summarize the percentage of influenza vaccine doses accounted for and administered and 
to summarize the characteristics of patients who received influenza vaccine. This data 
was compared for the three surveillance form formats. Fisher's Exact Test was used to 
assess the statistical significance of the difference in the proportion of doses accounted 
for and administered using each form and the odds ratio was used to assess the magnitude 
of any differences fomid. Content analysis was used to summarize the feedback received 
from the interview questionnaires. 
Ethical Considerations 
A written consent was not obtained in this study, however, elements .ofinformed 
consent were adhered to. By using letters of explanation and follow up phone calls to 
clarify any concerns practices may have had about completing surveillance forms, health 
care professionals were informed of the study's association with a Masters in Nursing 
research study. The letters of explanation also clearly explained what the health care 
professionals' participation involved. 
Health care professionals could refuse to participate by not returning completed 
forms. If health care professionals did not complete the individual or tally form they 
were sent the government form to complete. Health care professionals could also refuse 
to complete the government form. Consent was implied by the return of completed 
forms. Health care professionals could withdraw from the study at any time by not 
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returning completed forms . Verbal consent was obtained from every health care 
professional before the telephone interview took place. Health care professionals 
received a fax consisting of the interview questions several days before the interview 
which provided them with an opportunity to consider their interest in providing feedback. 
There was no penalty associated with not participating in this study and health 
care professionals did receive influenza vaccine as usual. Also, there was no penalty 
associated with not returning. unused vaccine, since all unused vaccine is normally 
destroyed. 
There was no harm associated with participating in this study. Influenza 
immunization surveillance forms only took a couple of minutes to complete and did not 
significantly add to the workload ofhealthcare professionals. There were several 
potential benefits for health care providers participating in this study. Respondents were 
provided with an opportunity to provide feedback on the immunization surveillance 
system used, and the initiative may have increased their awareness of vaccine eligible 
groups in their practices and, therefore, provided them with a chance to increase coverage 
rates. Patients may have benefited from the study as more vaccine eligible groups may 
have received vaccine if providers increased their coverage rates. Health and 
Community Services Eastern Region were provided with the opportunity to account for 
influenza vaccine doses distributed and the individuals receiving influenza vaccine. This 
data can assist health care professionals improve future vaccination rates in the 
community as they will know what groups should be targets for influenza immunization 
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promotion campaigns. 
Confidentiality was maintained in this study. The focus of this study was on 
practices and not individual health care professionals. There was no patient specific 
identifying information on the surveillance forms, nor was there any information 
identifying the health care professional completing the form. The surveillance forms 
were individually coded such that the investigator could assess the proportion of doses 
distributed to participating practices. A copy of the code identifiers were placed in a 
locked cabinet and used only for this aspect of data analysis. All the information 
received in this study was used for research purposes only. Data was reported in such a 
way that individual heath care providers and practices cannot be identified. 
This study had the support of the Eastern Region ofHealth and Community 
Services who also provided fmancial support. A letter outlining financial support can be 
found in appendix I. Finally, this study proceeded with the approval of the Human 
Investigations Committee (HIC) of Memorial University of Newfoundland. The letter of 
approval from HIC can be found in appendix J. 
CHAPTER4 
Results 
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The study findings are presented in seven sections. The first section presents 
health care professionals' participation, which is followed by a section on the distribution 
and administration of the influenza vaccine. Next are sections on the recipients' profile, 
completeness of the data collected, participant feedback and feedback from other 
provincial health regions. Finally, there is a section on the proportion of target groups 
vaccinated. 
Participation 
In the 2001-2002 season, Health and Community Services Eastern Region 
distributed influenza vaccine to 51 physicians and 15 community health nurses practising 
in the community. The individual and tally forms were sent to all of these physicians and 
community health nurses. Overall, 91.2% of health care professionals participated and 
returned surveillance forms. The community health nurses who were sent surveillance 
forms were all employed by Health and Community Services Eastern Board. All of the 
community health nurses who were sent surveillance forms participated by returning 
their randomly assigned forms. Forty percent (6 of 15) of nurses received and returned 
the tally form, and 60% (9 of 15) received and returned the individual form. 
Of all the physicians who were sent the tally and individual forn1s, 62.7% (32 of 
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51) returned their randomly assigned forms and 19.6% (1 0 of 51) returned the 
government form. All of these physicians were considered participants. Overall, 82.4% 
of physicians participated and returned surveillance forms . A total of 17.6% (9 of 51) of 
the physicians did not return any form and were considered non-participants. 
Table 1 shows that the distribution of forms between participating physicians and 
all physicians who originally received forms were similar for all forms. For example, 
there were similar proportions of participating physicians, 40.4% (17 of 42), and all 
physicians, 45.1% (23 of 51), that had the tally form. 
Table 1 
Distribution of Forms Between Participating Physicians and All Physicians Who Were 
Originally Distributed Forms 
Tally Individual Government Total 
Participating 1 n 17 15 10 42 
Physicians 
0/o 40.4 35.7 23.8 100 
All Physicians 2 n 23 18 10 51 
0/o 45.1 35.3 19.6 100 
. . .. 1 n and% are the number and proportion of 42 physiCians who participated and who received the specified 
form. 
2 n and % are the number and proportion of all the 51 physicians who were sent surveillance forms and 
received the specified form. 
Table 2 outlines the participation and non-participation of physicians in small and 
large clinics by the type of surveillance form they completed. There was no statistically 
significant difference between physicians practising in large and small clinics and 
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whether or not they participated (p=0.41 ). Therefore, physicians practising in larger and 
smaller clinics were equally likely to participate. 
Table 2 
Participation and Non-participation of Physicians in Small and Large Clinics by Form 
Type 
Tally 3 lndividual 4 ·· Government 5 Total 
n 0/o n 0/o n % n 0/o 
Participating Small
1 7 41.2 11 73.3 6 60 24 57.1 
Physicians Clinic 
Large 2 10 58.8 4 26.7 4 40 18 42.8 
Clinic 
Non- Small 1 3 60.0 3 75.0 0 0 6 66.7 
Participating Clinic 
Physicians 
Large2 2 40.0 1 25.0 0 0 3 33.3 
Clinic 
• 0 0 • • 0 1 Clmtcs wtth 2 or less phystcians practlsmg. 
2 Clinics with 3 or more physicians practising. 
3 n and'% are number and proportion of 17 participating physicians or 5 non-participating physicians who 
had the tally form. 
4 nand% are number and proportion of 15 participating physicians or 4 non-participating physicians who 
had the individual form. 
5 n and % are number and proportion of 10 participating physicians who had the government form 
Distribution and Administration of Influenza Vaccine 
There were 13,310 doses of influenza vaccine distributed to physicians and 
community health nurses practising in the community during the 2001-2002 influenza 
season. Ofthese 13,310 doses, 77.2% (10,270 of 13,310) were distributed to physicians 
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and community health nurses who returned the influenza immunization surveillance 
forms, while 22.8% (3,040 of 13,310) were distributed to physicians who did not return 
their surveillance forms. Of the total 10,270 distributed to health care professionals who 
participated, there were 472 of 10,270 doses distributed to participating community 
health nurses and 9,798 of 10,270 doses distributed to participating physician's offices. 
The influenza vaccine distribution ranged from 1,130 doses to 10 doses which were sent 
to individual offices and the median number of doses distributed was 200. The largest 
amount of vaccine distributed to one office was 1,130 doses. This was distributed to an 
office where there were 2 physicians practising. 
Ofthe total13',310 doses distributed, 51.3% (6,824 of 13,310) were known to be 
administered. There were four physicians who returned unused vaccine. This returned 
vaccine when added to the vaccine they documented as administered, will be referred to 
as "administered + returned" throughout this chapter and the chapters that follow. There 
was 57.5% (7,645 of 13,310) ofvaccine administered+ returned. If one considers only 
the 10,270 doses distributed to participating health care professionals, 66.4% (6824 of 
1 0,270) of the doses were known to be administered by using the three surveillance 
forms and 74.3% (7634 of 10,270) were administered +returned. Of those distributed to 
community health nurses, 95.5% (451 of 472) had been administered, whereas 
participating physicians administered 65.0% (6373 of9798) of the doses they had been 
distributed. The remainder of this section summarizes the results with the denominator 
of 10,270 doses which were distributed to health care professionals who participated. 
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Table 3 summarizes the distribution of influenza vaccine, as well as the doses 
administered and administered + returned, to health care professionals using the three 
surveillance forms. The highest proportion of influenza vaccine, 40% ( 4,150 of 1 0,270), 
was distributed to those health care professionals who received the individual form. 
Table 3 
Influenza Vaccine Distributed, Administered and Administered + Returned by Health 
Care Professionals Using the Three Surveillance Forms 
Tally Individual Government Total 
Doses Distributed nl 3,650 4,150 2,470 10,270 
o;0 1 35.5 40.4 24.1 100 
Doses Administered n2 2,292 2,409 2,123 6,824 
%2 62.7 58.1 86.0 66.4 
Doses Administered n 3 2,352 3,159 2,123 7,634 
+Returned o;0 3 64.4 76.1 86.0 74.3 
1 n and % are the number and proportion of 10,270 doses d1stnbuted to health care professiOnals, by form 
type. 
2 n and %are the number and proportion of doses distributed (tally n= 3650, individual n= 4150, 
government n= 2470) that were administered by health care professionals, by form type. 
3 nand% are the number and proportion of doses distributed (tally n= 3650, individual n= 4150, 
government n= 2470) that were administered + returned by health care professionals, by form type. 
Table 3 shows that of the 10,270 doses of vaccine distributed to participating 
health care professionals, 66.4% (6,824 of 10,270) were documented as administered on 
returned surveillance forms. Health care professionals that completed the tally form 
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documented that they administered 62.7% (2,292 of3 ,650) of the doses distributed to 
them. Health care professionals who completed the individual form documented that 
they administered 58.1% (2,409 of 4, 150) of the doses distributed to them. The highest 
proportion of distributed doses of influenza vaccine, 86.0% (2, 123 of 2,4 70), was 
documented by the health care professionals who completed the government form, all of 
whom were physicians. 
Table 3 shows that the government form identified a much higher proportion of 
doses administered (86.0%) than the tally (62.7%) or the individual forms (58.1%). The 
difference between the proportion of doses documented by health care professionals who 
completed the tally form and the individual form compared to the government form was 
statistically significant (p< 0.0005). In addition, the difference in the proportion of doses 
documented by health care professionals who completed the individual form compared to 
the tally form was also statistically significant (p< 0.0005). 
The vaccine administered + returned consisted of returned vaccine and 
administered vaccine. There were a total of830 (6.2%) doses returned from the 13,310 
doses distributed; twenty doses of the 830 returned were from non-participating 
physicians. Of the 810 doses returned from physicians who participated, 750 doses 
(92.6%) were returned from two physicians who had completed the individual form and 
60 (7.4%) were returned from one physician who completed the tally form. There were 
810 of 10,270 (8.1%) doses of influenza vaccine returned from participating health care 
professionals, with 710 of these doses returned by one physician's clinic. The remaining 
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100 doses came from two separate physicians' clinics. A larger quantity of vaccine was 
returned by physicians who completed the individual form, with 76.1% of the distributed 
doses administered + returned, compared to 58.1% documented as administered by 
health care professionals who completed the individual form, as shown in Table 3. With 
only a few doses of vaccine returned by those who completed the tally form, 64.4% were 
administered +returned compared to the 62.7% that were administered. Overall, the 
health care professionals who completed the government form administered + returned 
86.0% (2,123 of2,470) of distributed doses compared to 64.4% (2,352 of3,650) which 
were administered and returned by health care professionals that completed the tally 
form. The difference between the proportion of doses administered + returned by health 
care professionals who completed the government form (86.0%) and those who 
completed the individual (76.1 %) and tally forms (64.4%) was statistically significant 
(p< 0.0005). 
Figure 1 illustrates graphically the information presented in Table 3. It can been 
seen that health care professionals who completed the government form accounted for 
and administered the greatest proportion of the vaccine which they had been distributed 
compared to those who received the tally and individual forms. 
Figure 1 
Proportion Of Distributed Influenza Vaccine Doses That Were Administered, And 
Administered + Returned Using The Three Surveillance Forms 
Tally Individual Government 
r::l Distributed Administered 
0 Administered & Returned 
Recipient Profile 
Reasons why individuals received the influenza vaccine were identified on the 
individual and tally forms. The government form did not have a section for health care 
professionals to provide the reason why individuals received the vaccine. Health care 
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professionals that completed the government form were only required to identifY whether 
or not the individual receiving the vaccine was over or under 65 years of age. 
Age was thus the only item identified by all three surveillance forms. Of the 
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6,824 doses of influenza vaccine known to have been administered in the 2001-2002 
influenza season, 6,719 (98.4%) individuals had information provided regarding age. Of 
these 6,719 individuals, 2,716 (40.4%) who received the influenza vaccine were under 65 
years of age and 4,020 (59.8%) were 65 years of age and older. The government form 
identified 1,379 of 4,020 (34.3%) individuals who were 65 years of age and older and 
744 of2,716 (27.4%) of those under 65 years of age that received influenza vaccine. The 
tally form identified 1,262 of 4,020 (31.4%) that were over 65 years of age and 955 of 
2, 716 (3 5.2%) that were under 65 years of age. The individual form identified 1 ,3 79 of 
4,020 (34.3%) that were 65 years of age and older and 1,017 of2,716 (37.4%) that were 
under 65 years of age. 
Health care professionals who completed the individual and tally forms had a 
space provided so they could identify the recipient's date ofbirth as well as providing the 
reason for receiving the vaccine. Age was one of the reasons provided for individuals 
receiving influenza vaccine. There were 4, 701 doses of influenza vaccine administered 
by health care professionals who completed the individual and tally forms. The mean 
age for individuals receiving influenza vaccine was 64.8 years of age. The ages ranged 
from 3 to 102 years. 
Table 4 outlines the reasons why health care professionals who completed 
individual and tally forms administered influenza vaccine. 
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Table 4 
Reasons Individuals Received Influenza Vaccine Indicated by Health Care Professionals 
who Completed Tally and Individual Forms 
Tally Form 1' 4 Individual Form 2' 4 Total 
Reason n % n 0/o n % 
Age 949 41.0% 1001 41.5% 1950 82.5% 
Cardiac 649 28.3% 517 21.5% 1166 49.8% 
Pulmonary 512 22.4% 545 22.6% 1057 45% 
Diabetes 356 15.5°/o 320 13.3% 676 28.8% 
Other 3 314 13.7% 315 12.8% 629 26.5% 
Long Term Care 131 5.7% 162 6.7% 293 12.4% 
Facility 
Health Care 123 5.4% 115 4.8°/o 238 10.2% 
Professional 
Cancer 118 5.2o/o 105 4.4% 223 9.6% 
Renal 70 3.1% 59 2.4% 129 5.5% 
1 n and % ts the number and proportion of 2292 patients w1th reasons tdenhfied by health care professiOnals 
who completed the tally form. 
2 n and % is the number and proportion of 2409 patients with reasons identified by health care professionals 
who completed the individual form. 
3 Other is any reason health care professionals had for administering vaccine to their patient that was not 
identified as a reason on the form. Health care professionals were provided with a space where they could 
write in their other reason. 
4 The total % does not add up to 100% because many patients had more than one reason identified by health 
care professionals who completed both forms. 
Of the individuals with age identified as the reason for receiving influenza 
vaccine, 64.8% (1 ,263 of 1,950) had other reasons identified as well. Therefore only 
35.2% (687 of 1,950) of individuals had age identified as the only reason for receiving 
influenza vaccine. Similar proportions of health care professionals who completed the 
tally form, 41.0% (949 of2,292), and the individual form, 41.5% (1 ,001 of2,409) 
identified age as the main reason why they administered influenza vaccine to their 
patients. Four percent (78 of 1,950) of health care professionals identified age as the 
only reason why their patient received vaccine despite the fact that the individual 
receiving the vaccine was under 65 years of age. 
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Table 4 shows that chronic diseases such as cardiac disorders, pulmonary 
disorders and diabetes showed slight differences in proportions by form type. Other 
chronic conditions such as cancer and renal disease accounted for a total of9.6% and 
5.5% ofthe reasons provided. The category "other" accounted for a total of26.5% of 
reasons and 4.3% of these reasons were specified. Examples of the "other" reasons for 
receiving the vaccine consisted of chronic conditions such as lupus, anemia, multiple 
sclerosis, as well as individuals who were in close contact with those who were 
susceptible to contracting the influenza virus. Health care professionals only accounted 
for a total of 10.2% of the reasons identified. 
Overall, 3,416 of 4,701 (72.7%) forms returned provided reasons as to why their 
patient received the influenza vaccine. Ofthese 3,416 there were 1,252 (26%) patients 
who had more than one reason for receiving the influenza vaccine. More specifically, 
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905 (19.3%) had 2 identified reasons, 283 (6%) had 3 identified reasons, 51 (1.1 %) had 4 
identified reasons, and 13 (0.27%) had 5 identified reasons. 
In addition to the reasons why they were given vaccine, the patient's sex was 
identified by those health care professionals who completed the individual and tally 
forms. Ofthe 4,617 individuals who had their sex identified, 2,577 (55.8%) were female 
and 2,040 (44.2%) were male. 
The individual and tally forms also provided health care professionals with an 
opportunity to identify whether or not their patients received the influenza vaccine in the 
past season and if they had ever received pneumococcal vaccine. There were health care 
professionals who did not complete some of the questions on the surveillance forms, 
therefore, the denominator may change depending on the amount of missing data. Health 
care professionals who completed the tally or individual forms indicated that 84.6% 
(3,928 of the 4,643) of the individuals who received influenza vaccine in 2001-2002 also 
received the vaccine in the previous year. Only 15.4% (713 of 4,641) of those who 
received the vaccine in 2001-2002 did not receive it in the previous year. 
The majority, 70.9% (3,111 of 4,383), of individuals who received influenza 
vaccine in 2001-2002 did not receive pneumococcal vaccine in the past. There were 
1,277 of 4,388 (29.1 %) of those individuals who received influenza vaccine in the 2001-
2002 season that had received pneumococcal vaccine in the past. Of those 1,277 who 
received pneumococcal vaccine in the past, 999 (78.2%) were over 65 years of age in 
2001-2002. There were, however, 47.7% (1,465 of3,093) of individuals over 65 years of 
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age who did not receive pneumococcal' vaccine in the past. 
Completeness of Data 
There were data missing from some of the individual and tally forms that were 
returned. Unlike the individual and tally forms, the government form only consisted of 
two columns, one for individuals 65 years and over and one for individuals 65 years and 
younger. When completing the government form, health care professionals were 
required to tally up the doses they administered after each clinic and fill in the number on 
the form. Therefore, there were no missing data due to the nature of the form. 
The individual and tally forms had six questions which the health care 
professional had to complete. The completed forms that were returned did have missing · 
data from each item. There were 54 forms returned that had more than one item missing. 
Table 5 outlines the proportion of data missing from each item on the individual and tally 
forms. There was a higher proportion of missing data from the health care professionals 
who completed the tally forn1, since 346 of2,292 (15.0%) tally forms had at least one 
piece of data missing, compared to those who completed the individual forms, where 256 
of2,409 (10.6%) forms had at least one piece of data missing. An important question 
was the one related to reason for receiving the vaccine. There was very little missing 
data on the tally form (0.4%) or individual form (1.0%) related to this item. The majority 
of data was missing from the item related to whether the patient had received 
pneumococcal vaccine, with 170 of2,292 (7.4%) entries missing from the tally forms 
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and 148 of 2,409 ( 6.1%) missing from the individual forms. 
Table 5 
Proportion of Missing Data For Each Question by Tally and Individual Forms 
Tally 1 Individual 2 
n % n o;o 
Age 91 3.9 14 0.6 
Date ofVaccine 0 0 4 0.2 
Reason 9 0.4 24 1.0 
Sex 42 1.8 42 1.7 
Pneumococcal Vaccine 170 7.4 148 6.1 
Influenza Vaccine 34 1.5 24 1.0 
Total 346 15.0 256 10.6 
1 nand % are number and proportion of forms with the identified information missing from the 2292 tally 
forms completed. 
2 n and % are number and proportion of fom1s with the identified information missing from the 2409 
individual forms completed. 
Table 6 outlines the proportion of missing data from each question on forms 
completed by physicians and community health nurses. Both physicians, 13.1% (558 of 
4250), and community health nurses, 9.8% ( 44 of 451 ), had similar proportions of forms 
returned with missing data. 
Table 6 
Proportion of Missing Data For Each Question, by Physician and Community Health 
Nurse 
Physicians 1 Community 
Health Nurses 2 
n 0/o n o;o 
Age 104 2.4 1 0.2 
Date of Vaccine 4 0.1 0 0 
Reason 27 0.6 6 1.3 
Sex 76 1.8 8 1.7 
Pneumococcal Vaccine 296 7.0 22 4.9 
Influenza Vaccine 51 1.2 7 1.6 
Total 558 13.1 44 9.8 
1 n and % are number and proportion of forms with identified information missing from the 4250 forms 
completed by physicians. 
2 n and % are number and proportion of forms with identified information missing from the 451 forms 
completed by community health nurses. 
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Table 7 outlines the proportion of missing data from each question, by clinic size. 
Both large, 14.5% (176 of 1218), and small clinics, 12.2% (426 of 3483) had similar 
proportions of forms returned with missing data. 
Table 7 
Proportion ofMissing Data From Each Question, by Clinic Size 
Small Clinics 1 ~arge Clinics 
n 0/o n % 
Age 75 2.2 30 2.5 
Date of Vaccine 4 0.1 0 0 
Reason 29 0.8 4 3.3 
Sex 59 1.7 25 2.1 
Pneumococcal Vaccine 219 6.3 99 8.1 
Influenza 40 1.2 18 1.5 
Total 426 12.2 176 14.5 
1 
n and % are number and proportion of forms with the identified information missing from the 3483 
forms that were completed by health care professionals in small clinics. 
2 n and% are number and proportion of forms with the identified information missing from thel218 
forms that were completed by health care professionals in large clinics. 
Participant Feedback 
All of the health care professionals that were sent influenza immunization 
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surveillance forms were contacted to provide feedback on the forms. A total of 46 of the 
66 health care professionals (69.6%) provided feedback. All of the 15 community health 
nurses that were sent surveillance forms provided feedback, and of the 51 physicians that 
were sent surveillance forms, 31 (60.7%) responded to the feedback questionnaire. The 
20 physicians that did not provide feedback were contacted, however, they did not return 
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phone calls or return the copies of the questionnaires they had been faxed. 
Of the 51 physicians who were sent surveillance forms, 9 ( 17.6%) did not 
complete and return the tally or individual surveillance forms. Of those 9, only 2 
(22.2%) physicians provided feedback. There were 29 of the 42 (69.0%) physicians who 
completed surveillance forms that provided feedback on the surveillance forms. 
All of the community health nurses responded to the feedback questionnaire 
through a telephone interview, whereas, 26 ofthe 31 (83.8%) physicians that responded 
to the questionnaire were interviewed by telephone and the other 5 physicians ( 16.1%) 
were faxed a copy of the interview questions and returned them via fax because they 
were unable to be reached by telephone. 
The feedback which was received from health care professionals looked at the 
accuracy of data collected by using the surveillance forms and the acceptability of 
surveillance. In determining the accuracy of the data, all of the community health nurses 
provided feedback on the surveillance forms and they all felt that they were able to 
account for the vaccine they administered by using the forms. The majority of physicians 
who provided feedback, 79.3% (23 of29), felt they were able to account for most of the 
vaccine they administered by using the surveillance forms. There were 20.7% (6 of29) 
of physicians that stated they were not able to account for the vaccine they administered 
by using the surveillance forms they had been provided. One physician forgot to 
complete the tally forms he had received for the first few clinics and stated he did keep a 
list of those be had vaccinated so he completed the forms from the list. The other 
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physicians stated reasons such as they forgot to complete forms on several occasions, or 
they forgot to carry forms to their home visits and personal care homes for completion. 
In addition, one physician who completed the government form indicated that he 
administered more vaccine (20 doses) than he actually received. 
The acceptability of surveillance was also determined through the feedback 
provided by health care professionals. The majority of community health nurses, 86.6% 
(13 of 15), and physicians, 72.4% (21 of 29), that provided feedback revealed they would 
like to see the same surveillance form used in the future. The two nurses who did not 
feel they would like to see the form used again both completed the individual form and 
felt that the form would be easier to complete if it was formatted as a tally sheet. They 
stated that there was too much paper and there would be less paper if information for 
several individuals was condensed on one sheet. The eight physicians who felt they 
would not like to use·the form in the ·future consisted of six physicians who completed 
the individual forms and two who completed the tally forms. They stated several reasons 
why they would like to see the forms changed. They felt that fewer items to complete on 
each patient would be better, and those who completed the individual form would have 
liked a tally form type or would like a form that would not take so much time to 
complete. 
All the community health nurses felt that influenza immunization surveillance in 
general is a good idea. Two of the nurses elaborated on their opinion of influenza 
immunization surveillance by stating that it is important to determine the number of 
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doses of influenza vaccine administered and to whom they are administered as it should 
help prepare for future pandemics. 
The majority of physicians, 22 ofthe 29 (75.8%) who completed the forms, felt 
that influenza immunization surveillance was a good idea. They felt that surveillance 
was a good way to collect statistical information about influenza vaccinations, as well as 
a good way to determine who is not getting vaccinated if there is a way to determine 
denominator data. Two physicians stated that surveillance was a great idea and they had 
been collecting this information for their own practices for the past few years as a way to 
keep track of who was receiving the vaccine. 
Seven of the 29 {24.1%) participating physicians felt that they could not see the 
benefit of influenza immunization surveillance. They felt that surveillance was not 
important and they could not see the benefit of such a surveillance system. They also felt 
that they did not have time to collect influenza immunization surveillance data, and that 
doctors do not appreciate another task or form to complete. 
There were two physicians who answered the questions on the non-respondent 
questionnaire. One of the physicians stated that he did not have a problem with the 
individual form which he had been sent, however he did not receive the forms until after 
his influenza vaccination clinic was completed. He was, therefore, unable to complete 
the forms and stated he would participate in the future if he was to receive the forms on 
time. The other physician misunderstood how he was supposed to complete the tally 
forms he had been sent and only completed one ofthe tally sheets he received. He felt 
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that he was only supposed to provide a cross section of the influenza vaccines he 
administered for the season rather than complete information on every patient vaccinated. 
Both physicians felt that influenza immunization surveillance is a good idea. However, 
one of the physicians stated he did not see influenza immunization surveillance as a 
priority. 
The amount of time required to collect surveillance data was also an important 
factor when determining health care professionals' acceptance of surveillance. 
Participating community health nurses and physicians that provided feedback stated that 
it took approximately one minute to complete the information on each patient who 
received the influenza vaccine. The highest number of surveillance forms returned from 
one health care professional was 337. These forms were completed by a physician. It 
therefore took that particular physician a total of 5.6 hours to complete the influenza 
immunization surveillance forms, spread over several weeks. This physician provided 
his influenza vaccinations from October 26, 2001 to December 6, 2001. The first week 
this physician vaccinated 155 patients which would amount to 2.5 hours that week spent 
on completing surveillance forms. The second week the physician vaccinated 165 
patients which took him 2.75 hours that week to collect influenza immunization 
surveillance data. Therefore, the maximum amount of time spent on completing the 
surveillance forms was only 2.75 hours a week for two weeks of the entire year. The 
minimum amount of time spent on completing surveillance forms was ten minutes 
because the least number of forms sent in by a health care professional was ten. The 
average number of forms returnedwas 20;9. Therefore, it only took health care 
professionals an average of 20.9 minutes to complete surveillance forms per influenza 
season. 
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There were 25 of the 29 (86.2%) physicians who stated they completed the forms 
themselves, 3 of the 29 (13.8%) stated that their secretary was responsible for completing 
the forms, and 1 (3.4%) physician who stated a nurse was responsible for completing the 
forms. The physician who returned the most forms (337) did complete the forms 
himself, and all the community health nurses completed their forms. 
In addition to the time taken by health care professionals who completed the 
forms, there was also time spent by those individuals of Health and Community Services 
Eastern Region, who were responsible for organizing, sending out and collecting the 
influenza immunization surveillance forms. It took approximately 12 hours to put 
together the information and forms and send it to the appropriate health care 
professionals. There was time involved in entering the surveillance data once the forms 
were returned. It took approximately one minute to enter the information on one form. 
There were 4701 forms returned that required data entry. Therefore, it took 
approximately 78.4 hours to enter the surveillance data, using 7.5 hour workdays this 
would equate to 10.5 work days. It took a total of three work days to get feedback from 
healthcare professionals and send out reminders to return forms. It therefore took a total 
of 112.9 hours, which amounts to 15 (7.5 hour) work days to carry out this entire 
surveillance initiative. 
Feedback from Other Provincial Health Regions 
There were five other provincial Health and Community Services Regions that 
used the government influenza immunization surveillance forms in the 2001-2002 
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season. Communicable disease control nurses were contacted by phone for each of the 
five regions to obtain information regarding the proportion of forms returned and the 
doses of influenza vaccine accounted for by using the government form. Information was 
obtained for three of the five regions, however, the communicable disease control nurses 
contacted did not have precise data available to share. One of the regions only received 
approximately 30% of the forms they distributed to the health care professionals in their 
region and there was only approximately 30% of the distributed vaccine accounted for by 
using the government form. The majority of the health care professionals in this region 
that administered influenza vaccine were physicians (personal communication, 
communicable disease control nurse, March 20, 2003). 
One of the other regions that provided information about the surveillance forms 
showed that 40% of health care professionals returned influenza immunization 
surveillance forms with approximately 25% to 30% of the vaccine accounted for. The 
majority of health care professionals who administered influenza vaccine in this region 
were also physicians (personal communication, communicable disease control nurse, 
March 19, 2003). 
The final health care board obtained 90% of the forms they disttibuted to health 
care professionals and accounted for nearly 90% of the vaccine that had been distributed 
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(personal communication, communicable disease control nurse, March 19, 2003). This 
region was different than the two previous regions in that 84.2% of the health care 
professionals that administered vaccine in this region were community health nurses . 
Target Groups Vaccinated 
Although the purpose of this study was to assess the effectiveness of using 
surveillance forms to account for the influenza vaccine distributed, the results can be 
used to estimate vaccine coverage rates, since it provides numerator data on individuals 
65 years of age and older and individuals living with diabetes. 
Denominator data was available for age and individuals living with diabetes for 
the Eastern Region of Newfoundland and Labrador. There was no denominator data 
available for the other ·chronic diseases or target groups that was region specific. There 
were 16,905 individuals 65 years ofage and older living in the Eastern region of the 
province ofNewfoundland and Labrador in 1996 (Centre for Health Information, 2000). 
There were 4,020 individuals 65 years of age and older identified as receiving influenza 
vaccine in the community setting during the 2001-2002 season. Assuming that the 
number of individuals age 65 years and older residing in this region of the province has 
not changed significantly, only 25.0% (4220 of 16,905) of individuals in this target group 
were documented as receiving influenza vaccine for the 2001-2002 season. 
There were 676 individuals with diabetes identified as the reason why they 
received influenza vaccine. In 2001, there were 6,269 individuals over the age of 12 
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living with diabetes in the Eastern Region of the province (Canadian Institute for Health 
Information, 2001). Assuming that the denominator data was accurate, 10.7% of those 
with diabetes were identified as receiving the influenza vaccine because they haq 
diabetes. 
Summary 
The results of this study showed an overall participation rate of 91.2%, with a 
100% response rate from the community health nurses and 82.4% from physicians. The 
non-participants did not significantly differ based on the forms they had been sent or the 
size of their clinic. 
There were 13,310 doses of influenza vaccine distributed to health care 
professionals practising in the community during the 2001-2002 season. Ofthese 13,310 
doses, 51.3% were administered and 57.5% wereadministered+ returned. There were 
10,270 doses distributed to health care professionals who participated in the surveillance 
initiative, of which 66.4% were administered and 74.3% were administered + returned. 
Community health nurses administered 95 .5% of the doses they had been distributed, 
whereas, physicians administered 65.0% of those they had been distributed. 
Health care professionals who completed the government form documented the 
highest proportion, 86.0%, of the vaccine distributed compared to 62.7% for the tally 
form and 58.1% for the individual form. The difference was statistically significant 
when comparing proportions documented for all three forms (p<0.0005). 
There were a total of 810 doses returned by health care providers who 
participated. Those who completed the government form administered +returned a 
statistically significantly higher proportion, 86%, of the vaccine they had been 
distributed, than those who completed the individual form, 76.1 %, and the tally form, 
64.4% (p<0.0005). 
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The individual and tally forms contained more items than the government form 
and thus provided more information about vaccine recipients. Age was the only item 
identified by all three surveillance forms. Over half the individuals, 59 .8%, who received 
influenza vaccine were over 65 years of age. Of the individuals with age identified as a 
reason for receiving influenza vaccine, 64.8% had other reasons identified as well. 
Health care professionals who completed the tally and individual forms indicated that 
84.6% of those who received the vaccine this year also received the vaccine last year. In 
addition, 70.9% of individuals who received influenza vaccine in the 2001-2002 season 
did not receive pnemococcal vaccine in the past. 
There were very little ·missing data from the individual and tally forms, especially 
for the question relating to the reason for immunization. There was no difference in the 
amount or type of data missing from the forms completed by community health nurses or 
physicians, nor was there a difference in the data missing from forms returned by small 
or large clinics. 
All of the community health nurses who provided feedback felt they were able to 
account for the influenza vaccine they had administered by using the surveillance forms. 
72 
Over half ( 60.7%) of physicians provided feedback. Of the physicians who provided 
feedback, 79.3% felt that they could account for the vaccine they had administered by 
using the surveillance forms. Those who felt they could not account for the vaccine 
stated it was because they forgot to complete the forms on different occasions. The 
majority of community health nurses, 86.6%, and 72.4% of the physicians that provided 
feedback revealed that they would like to see the same form used again. All of the 
community health nurses and 75.8% of the physicians interviewed felt that influenza 
immunization surveillance is a good idea. 
The time taken to complete surveillance forms varied depending on the doses of 
vaccine administered by the health care professional. Health care professionals felt that 
the forms took one minute to complete and the most time spent on completing 
surveillance forms was 2.75 hours a week for two weeks of the entire year. There were 
approximately 15 (7.5 hour) workdays required to organize, send out, collect and enter 
surveillance data. This time also included reminding health care professionals to send 
out forms and collecting feedback on the surveillance initiative. 
There were three of the five other regions in the province that provided · 
information about their influenza immunization surveillance initiatives. This study 
accounted for considerably more vaccine than two of these provincial regions. There was 
one region that accounted for 90% of the vaccine distributed. This particular region had 
a higher proportion of community health nurses, 84.2%, administering influenza vaccine 
than the Eastern region and the other two regions that provided feedback. 
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Denominator data were available for individuals under and over 65 years of age 
and diabetics. Twenty five percent of individuals 65 years of age and over and 10.7% of 
diabetics who were residing in the Eastern region of the province were documented as 
receiving the influenza vaccine. 
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CHAPTERS 
Discussion 
This chapter presents a discussion of the study's fmdings. The first section will 
discuss the study's results in relation to the CDC (2001) guidelines for evaluating a 
surveillance system. The second section draws conclusions on how to improve influenza 
immunization surveillance. Finally, the third section discusses how to improve the 
surveillance of target groups. 
Evaluation of Surveillance Forms and Systems 
The purpose of this study was to assess a new surveillance system as a way to 
monitor who is receiving influenza vaccine. For such a system to be effective it must 
collect useful information, obtain complete and accurate data, and obtain data from 
everyone who administers influenza vaccine. To determine if the surveillance system 
used in this study was an effective system to collect influenza immunization surveillance 
data, it is important to evaluate the system. Therefore, the study's findings will be 
discussed in the context of CDC (200 1) guidelines for evaluating a surveillance system. 
These guidelines include seven criteria that are considered important to follow when 
evaluating a surveillance system: sensitivity, adequate positive predictive value, 
simplicity, acceptability, flexibility, representativeness, and timeliness. Because all 
surveillance systems vary widely in methodology, scope, and objectives, criteria that are 
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important to one system may be less important to another (CDC, 2001). 
Sensitivity was one of the criteria used to evaluate the surveillance system and 
the influenza immunization surveillance forms used in this study. The sensitivity of a 
surveillance system can be defined as the system's ability to detect the proportion of 
cases of a disease or health condition, as well as the system's ability to detect epidemics 
(CDC, 2001). The surveillance system in this study was not designed to detect health 
conditions or epidemics, instead it was developed to account for the doses of influenza 
vaccine administered in the 2001-2002 season. Therefore, the sensitivity of the influenza 
immunization surveillance forms and the overall surveillance system used in this study 
were determined by evaluating its ability to account for the proportion of influenza 
vaccine doses administered and those administered + returned. 
Positive predictive value refers to determining if an identified case is actually a 
true case (CDC, 2001). This criterion was applied to influenza vaccination surveillance, 
in terms of knowing if vaccine recipients truly received the vaccine. 
The simplicity of a surveillance system refers to both its structure and ease of 
operation. The surveillance system should be as simple as possible while still meeting 
the system's overall objectives (CDC, 2001). The acceptability of the system reflects the 
willingness of the health care professionals in this study to participate and use the 
surveillance forms. The simplicity of the influenza immunization surveillance system 
used in this study will be discussed along with the system's acceptability to health care 
professionals. 
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Flexibility is another criterion that was used to evaluate the surveillance system 
used in this study. Flexibility refers to the system's ability to accommodate new diseases 
and health conditions (CDC, 2001). The influenza immunization surveillance system 
used in this study was designed to collect influenza immunization data. However, this 
system can capture information on other vaccines, such as the pnemococcal vaccine, if 
seen as important by the Department of Health and Community Services. 
Another criterion used to evaluate the surveillance system used in this study is 
representativeness. A surveillance system is representative if the data obtained from the 
system actually reflects that of the target population (CDC, 2001). An ideal influenza 
immunization surveillance system would obtain data that is representative of the entire 
population. There are two methods of obtaining a representative surveillance system. 
One method is to have 100% participation from health care professionals who administer 
the vaccine, and the second method is to obtain a sample of health care professionals that 
administer vaccine to a population that is representative of the actual target population. 
Study results are discussed in the context of the first approach. 
The final criterion is timeliness. The timeliness of a surveillance system should 
be evaluated in tenns of the availability of information to identify trends, outbreaks, or 
the effects of control efforts (CDC, 2001 ). It is important to receive the influenza 
immunization data as early in the influenza season as possible, since data specific to the 
season would help guide interventions for increased uptake in the same influenza season. 
This study' s results will be discussed along with the study conducted by 
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Macdonald et al. (1996) and with some reference to the Manitoba Health (2000) study. 
These studies were conducted on influenza immunization surveillance in the community 
setting and were previously discussed in Chapter 2. This present study, along with these 
studies, can increase the understanding of how to create an influenza immunization 
surveillance system that is effective and acceptable. 
Overall Sensitivity 
The sensitivity of a surveillance system can be defined as the system's ability to 
detect the proportion of cases of a disease or health condition, as well as the system's 
ability to detect epidemics (CDC, 2001 ). When determining the sensitivity of a 
surveillance system one has to consider the system's ability to measure the proportion of 
cases detected by the surveillance system. Since a purpose of this study was to obtain 
data on everyone who received the influenza vaccine, the ability of the surveillance 
system to account for the proportion of influenza vaccine doses administered would 
determine the system's overall sensitivity. 
To discover the overallsensitivity of the surveillance system used in this study, 
·the proportion of administered · doses documented was determined. The sensitivity of the 
surveillance system used in this study was fair due to the system's ability to account for 
57.5% of all vaccine that had been distributed to health care professionals. The 
sensitivity was high~r (74.3%) when looking at the doses of influenza vaccine accounted 
. . . 
for by only participating health care professionals, since there were 13.6% of health care 
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professionals that did not participate. This finding is disappointing, since the 
surveillance system should account for 100% of the doses distributed. However, when 
comparing this surveillance system to the government surveillance system used during 
the same season by two of the other health regions of the province, the overall sensitivity 
of the surveillance system used in this study was much better. The government 
surveillance system in these regions accounted for 25-30% and 30% of the influenza 
vaccine distributed. 
The greater overall sensitivity of the surveillance system used in this study 
(57 .5%) may be attributed to the structured system that was put in place prior to initiating 
the influenza immunization system. All health care professionals were provided with a 
letter explaining the surveillance system prior to receiving their surveillance forms and 
all forms were asked to be returned to the MOH once completed. Health care 
professionals were also reminded to return fmms on a monthly basis and were provided 
with self addressed stamped envelopes to return forms. This made it very easy for health 
care professionals to return completed forms and reminding them to return forms may 
have decreased the chance of not returning them. This structured system was not in place 
in the other health regions and health care professionals were simply sent the government 
form and asked to return it when influenza immunization clinics were completed. This 
may be a reason why the sensitivity of two of the other provincial health regions was 
very low (25% - 30% and 30%). There was one provincial region who reported 
accounting for 90% of the vaccine distributed. This provincial region differed from the 
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other regions, as well as this study's region, in that the majority of the vaccine was 
· distributed to community health nurses (82.4%). This difference will be discussed later 
in this section. 
The overall sensitivity of the surveillance system used in this study is similar to 
that stated in the report of the study conducted by Macdonald et al. (1996). Macdonald et 
al. reported that the health care professionals in their study administered 77.7% of the 
doses they had been distributed. Because Macdonald et al. did not include, in their 
denomiator, the doses distributed to those health care providers who did not participate, 
the doses documented as administered should be compared to the 74.3% of doses 
documented as administered + returned by participating health care professionals in this 
study. The supportive structure that was in place in both this study and the study by 
Macdonald et al. may be a reason why both studies have comparable systems in terms of 
their sensitivity. In addition, the results of the study by Macdonald et al. showedthe 
sensitivity of a surveillance system after a pilot project had already been implemented. 
The sensitivity of a system similar to the one used in this study may be greater if it is 
tried again with recommendations added from the feedback received from the health care 
professionals who used the system. 
Feedback was also received from health care professionals to determine if they 
were able to account for the vaccine they administered by using the surveillance forms. 
This data provides an indicator of the system' s overall sensitivity. All of the nurses and 
the majority ofphysicians(79.3%) felt they were able to account for most of the vaccine 
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they administered by using the surveillance form they had been provided. The six 
physicians who stated they were not able to account for all the vaccine administered did 
not feel it was because of the nature of the form. They did not state that the form did not 
allow them to account for the vaccine administered. Instead, it was mainly because they 
forgot to complete the forms ·on several occasions. This feedback supports the 
conclusion that health care professionals felt they were able to account for most of the 
vaccine they had administered by using the surveillance form. 
The sensitivity of the surveillance system differed depending on whether the 
forms were completed by community health nurses or physicians. In this study 
community health nurses documented 95.5% of the doses they had been distributed, 
however they only received 3.5% of the overall doses distributed. The other Health and 
Community Services Regions of the province that provided feedback on the information 
obtained from their surveillance initiative showed that the region that had the highest 
proportion of nurses administering vaccine (84.2%), had the highest proportion of forms 
returned and doses of influenza vaccine accounted for (90%). In addition, the public 
health nurses in the study by Macdonald et al. (1996) received 23.7% of the doses 
distributed and administered and documented the highest proportion of the doses 
distributed, 86.9%. 
In comparison, physicians in this study documented 65.0% of the doses of 
influenza vaccine they received, which was slightly higher than the propmiion reported 
in the study by Macdonald et al. (1996) in which physicians documented 52.3% of doses 
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they had been distributed. In this study, the physicians received 96.5% of the doses 
distributed. In the study by Macdonald et al. physicians received 61.9% of the doses 
distributed. The surveillance systems in this study and in the study by Macdonald et al. 
were less sensitive when used by physicians. 
The reason why the surveillance system was seen as highly sensitive when used 
by community health nurses may be due to the fact that community health nurses in the 
Eastern Region of Health and Community Services are familiar with collecting 
immunization data since they provide over 80% of childhood immunizations in the 
region (personal communication, Patricia Heath, Communicable Disease Control 
Coordinator Eastern Region, November 24, 2002). If there had been more community 
health nurses administering influenza vaccine in this study, there may have been a greater 
proportion of doses documented on the surveillance forms as seen in the study by 
Macdonald et al. ( 1996) and in the other provincial region. This supports increasing the 
use of nurses in administering influenza vaccine. However, it is important to remember 
that the community health nurses in this study only received 3.5% of all the vaccine 
distributed in the 2001-2002 season. It is possible that if community health nurses 
administer more vaccine in future seasons, because of their increased workload they may 
not document such a high proportion (95.5%) of vaccine administered on the surveillance 
forms. However, the data from the region that had a high proportion of nurses 
administering vaccine (90%), suggests that community health nurses were still able to 
account for the vaccine they administered. 
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Sensitivity by Surveillance Form 
The influenza immunization surveillance forms were compared to determine 
which form had the highest sensitivity for collecting influenza immunization surveillance 
data. There were no previous studies found that compared surveillance forms. In 
comparing the three forms for doses administered, this study revealed that health care 
professionals who completed the government form documented the highest proportion of 
influenza vaccine (86.0%), compared to the tally form (62.7%) and the individual form 
(58.1 %). By using Fisher's Exact Test, the differences in the proportion of vaccine 
documented between the government and tally form, government and individual form, 
and the tally and individual form were all found to be significant (p<0.0005). This shows 
that health care professionals who completed the government form documented a 
statistically significantly higher proportion of vaccine, than those who completed the 
individual and tally forms. Therefore the government form had the highest sensitivity for 
accounting for the doses of vaccine administered. 
Similarly, significantly higher proportions were accounted for when looking at 
the administered + returned vaccine. Health care professionals who received the 
government form again documented the highest proportion of influenza vaccine (86.0%), 
compared to the individual form (76.1%) and the tally form (64.4%) (p<0.0005). Despite 
the fact that the individual form had a higher proportion of vaccine administered + 
returned than the tally form, the results were skewed because there were only three 
physician's offices who returned vaccine and the majority of doses (71 0) were returned 
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by one physician who had received the individual form. 
In summary, when comparing forms to determine which form had the highest 
sensitivity for accounting for the number of doses administered as well as the number of 
doses administered +returned, the government form was the best. However, the tally 
form accounted for a significantly higher proportion of documented vaccine than the 
individual form (p<0.0005). Therefore, this form showed a higher sensitivity 
than the individual form in accounting for the number of doses of influenza vaccine 
administered. 
Vaccine Wastage 
Although this study focussed on accounting for the number of doses of influenza 
vaccine administered, this study's results showed there were 5,656 doses of influenza 
vaccine unaccounted for. There were only 830 doses returned from three physicians' 
offices, of which 710 were returned from one physician's office. With such a small 
proportion of vaccine returned and a large number of vaccine doses unaccounted for 
( 5,65 6) it is unknown if this vaccine was unused, or if it was administered and not 
documented as such. 
It is, therefore, very important to determine ways to account for unused vaccine. 
Whether health care professionals complete a separate form at the end of the season 
stating the amount of vaccine unused and discarded, or are asked to return unused 
vaccine in order to receive vaccine in the next season, a system is required to track 
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unused vaccine. Determining the amount of unused influenza vaccine would also help 
determine the sensitivity of future influenza immunization surveillance systems, because 
if the vaccine that was unaccounted for was administered and not documented as 
administered the sensitivity would be as calculated 57.5%. However, if all the 
unaccounted for vaccine was actually unused the sensitivity of the system would be 
100%, because the forms would have accounted for all of the administered influenza 
vaccine. It was not anticipated prior to the initiation of the study that health care 
professionals would not return unused vaccine, since there was no data available from 
previous seasons to indicate that this would occur. Therefore, a structured method of 
accounting for unused vaccine had not been implemented. A method to track unused 
vaccine would have been useful when evaluating the influenza immunization surveillance 
system used. It would, therefore, be beneficial to implement a structured method to track 
unused vaccine in future influenza immunization surveillance initiatives. 
Summary of Sensitivity 
To promote influenza immunization surveillance in the future it is important to 
choose the most appropriate surveillance system. The overall sensitivity of the 
surveillance system used in this study was fair because it was able to account for 57.5% 
of the doses distributed. Those who participated accounted for 74.3% of the vaccine 
doses they had been distributed. Therefore, if there was higher participation in future 
influenza immunization surveillance initiatives, there would be at least 74.3% of vaccine 
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accounted for. It is also important to remember that the actual sensitivity of the system 
was difficult to detennine because there were 5,656 doses of influenza vaccine that were 
unaccounted for. This shows that there needs to be a greater emphasis placed on 
accounting for unused vaccine in future influenza immunization surveillance initiatives, 
which would also improve sensitivity. 
The sensitivity of the surveillance system varied depending on who completed the 
surveillance forms. With a greater proportion of doses documented by community health 
nurses, the sensitivity of the surveillance system was higher than when the system was 
used by physicians. This finding supports the use of community health nurses to 
administer more influenza vaccine. One must, however, take into account that the 
community health nurses in this study only received 3.5% of the total distributed vaccine. 
If community health nurses administer more influenza vaccine in the future it may 
increase their workload, therefore, strategies may need to be implemented to ensure that 
they can continue to account for as much of the vaccine doses as they did in this study. 
Health care professionals who completed the government form accounted for a 
greater proportion of doses administered and administered + returned than those who 
completed the individual and tally forms. This finding shows that the government form 
was the most sensitive form, suggesting that it would be the best form to use if sensitivity 
were the only criterion to consider in finalizing decisions about influenza immunization 
surveillance. 
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Positive Predictive Value 
Positive predictive value, primarily used in screening tests, determines the 
proportion of persons identified as being cases, who actually do have the condition under 
surveillance (CDC, 2001). The positive predicative value of this surveillance system was 
considered as the proportion of individuals documented as receiving influenza vaccine 
that actually received the vaccine. In comparison to sensitivity, which refers to the 
system's ability to account for the proportion of influenza vaccine doses administered 
and those administered +returned. For the surveillance system used in this study, the 
positive predictive value was difficult to determine, because the study was not set up to 
obtain the data required to validate that a person to whom vaccine was administered and 
documented actually received vaccine. 
The government form may have a lower positive predictive value than the 
individual and tally forms because of the nature of the form. The government form 
required health care professionals to place a tick on the form and then tally up the total 
number of individuals receiving vaccine on the form at the end of each clinic. In 
comparison, the tally and individual forms required health care professionals to provide 
specific information about each vaccine recipient. Therefore, those who completed the 
government form may have been more likely to indicate that an individual received the 
influenza vaccine when they actually did not receive it. There was one physician who 
completed the government form and documented administering 20 more doses than this 
particular physician actually received, however other than this incident the accuracy of 
the data received from the government form was difficult to determine. This was the 
only incident of an inaccurate count. Overall the accuracy of the data was difficult to 
determine. 
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Overall, there was no reason to believe that anyone would complete a form on an 
individual, or indicate that an individual received influenza vaccine, if the vaccine was 
not given. Therefore, there is no reason to believe that the surveillance system used in 
this study has a weak positive predictive value. 
Simplicity and Acceptability 
Determining if a surveillance system is simple and acceptable to those who use it 
are two important factors to look at when evaluating a surveillance system (Centre for 
Disease Control, 1988). The simplicity of a surveillance system refers to both its 
structure and ease of operation. A surveillance system should be as simple as possible 
while still meeting its overall purpose. A simple surveillance system will lead to a 
system that is better accepted by those who have to use it, which will in tum increase the 
willingness of individuals to participate. It was, therefore, important to determine if the 
surveillance forms used in this study were seen as a simple method to collect influenza 
immunization data by the health care professionals who administered influenza vaccine. 
If health care professionals viewed the surveillance forms as simple to complete they 
would be more likely to accept the surveillance forms, and the same surveillance forms 
could be used in future seasons. If the surveillance forms were complicated to use, health 
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care professionals would probably be less likely to use them in the future. 
As a way to determine whether or not health care professionals accepted the 
surveillance forms used in this study, they were asked,to provide feedback on the forms. 
The other studies that had been conducted on influenza immunization in the community 
did not obtain feedback from the participants about the surveillance initiative 
(Macdonald et al.l996; Manitoba Health, 2000). All of the health care professionals that 
were sent surveillance forms were contacted after surveillance forms were returned to 
provide feedback on the forms. All of the community health nurses that were contacted 
provided feedback and 60.7% of physicians provided feedback. 
The majority of the health care professionals who provided feedback (86.6% of 
community health nurses and 72.4% of physicians) revealed that they would like to see 
the same surveillance form used again. There were a total of 10 health care professionals 
who would have liked to see the surveillance form changed, 8 of whom completed the 
individual form. The main reason why they wanted to change the form was because 
there was too much paper by having to complete one sheet per patient, and so they would 
have liked to see the form condensed into a tally style form. Therefore, if these health 
care professionals had received the tally form, they may not have had a problem with 
using the same form in the future. This feedback supports the use of a tally form in 
future influenza immunization surveillance initiatives. 
Health care professionals in this study were also asked to provide feedback on 
their opinion of influenza immunization surveillance in general. All of the community 
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health nurses felt that influenza immunization surveillance is a good idea. Community 
health nurses play a key role in immunization surveillance since they provide and 
document immunizations on a regular basis (Zahner, 1999). Community health nurses 
use the data they collect from immunization surveillance to plan and evaluate 
immunization programs. A few of the nurses elaborated on their feedback and provided 
insight regarding the connection between influenza immunization surveillance and 
preparing for pandemic influenza. They stated that pandemic influenza planning is 
ongoing and completing influenza immunization surveillance forms would help 
determine who is and is not receiving the vaccine. This would help nurses focus 
campaigns on those who do not receive the vaccine to try and increase uptake before a 
pandemic strikes. By analysing the nurses' feedback regarding surveillance, one can 
easily see that nurses view surveillance as an essential method to collect and evaluate 
immunization data. 
The majority (77 .4%) of all physicians who provided feedback also felt the 
influenza immunization surveillance was a good idea. Some of the physicians stated that 
they have been collecting influenza immunization data for years. They had not been 
forwarding the information on to the provincial level, but used the information to 
compare their individual practice influenza vaccination rates from year to year. Influenza 
immunization surveillance is obviously not something new to some physicians in the 
Eastern Region of the province. 
There were 24.1% of physicians who did not feel influenza immunization 
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surveillance was of any benefit. They felt that surveillance was not important and they 
did not have time to collect this data. Those physicians who did not feel influenza 
immunization surveillance was important all felt that they did not want to see the same 
surveillance form used again. They stated that they would like to have a form with fewer 
items to complete on each patient, and those who completed the individual form would 
have liked a tally form type or a form that would not take so much time to complete. 
These physicians did not feel surveillance was important and therefore, may not have 
agreed to use any form in the future. It is important to educate physicians about the 
importance of influenza immunization surveillance as a way to help increase their 
participation in future surveillance initiatives. 
Time was not seen as a great concern for those who completed the surveillance 
forms, since the forms did not take much time for health care professionals to complete. 
Health care professionals estimated that it took about one minute to complete the 
information on each person vaccinated, with the maximum amount of time spent to 
complete the surveillance forms being 2.75 hours a week for approximately two weeks a 
year. Because it only took one minute to complete each form, time would probably not 
be a factor as to why health care professionals would not accept the surveillance forms in 
future initiatives. 
Overall, the feedback received from health care professionals showed that using 
influenza immunization surveillance forms was a simple and acceptable way to collect 
influenza immunization surveillance data. The feedback also showed that of the 
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individual and tally form, the tally form was the form they would like to see used again. 
Those who completed the individual form and did not like it wanted the form to be in the 
format of a tally sheet. Therefore, the tally form was the most accepted form of the two 
and would be the most appropriate form to use in future seasons if using this criteria 
only. All of the nurses were strongly in favour of influenza immunization surveillance 
and indicated that they understood the importance of such an initiative. The majority of 
physicians felt influenza immunization surveillance was important, however, a 24.1% 
could not see the importance of surveillance and would not like to see such an initiative 
added to their current workload, even though time was not a major issue for health care 
professionals when completing the forms. It only took a minute to complete the 
information on each individual which made the forms that much more acceptable to 
health care professionals. Withincreased awareness ofthe importance of influenza 
immunization surveillance, these physicians may become more enthusiastic about 
participating in future surveillance initiatives. 
Complete, Accurate and Useful Data 
It is important to determine the completeness of the data received from the 
returned surveillance forms, since incomplete data would influence the sensitivity of the 
surveillance system used. The more information completed by health care professionals, 
the better the surveillance system is in determining the proportion of individuals 
vaccinated and developing a profile of recipients. 
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When completing the government form, health care professionals were only 
expected to tally up the doses administered after each clinic and fill in the number on the 
form. Therefore, there were no missing data due to the nature of the government form. 
Health care professionals that completed the individual and tally forms had six items to 
complete and there were similar proportions of data missing from both the individual 
and tally forms, with 10.6% and 15 .0%, respectively, having at least one piece of data 
missing. The tally and individual forms had a space for health care professionals to 
document the reason why individuals received the influenza vaccine. This item was the 
most important since it provided numerator data for those vaccine eligible groups who 
received influenza vaccine. There was 99.6% of this information provided by health care 
professional who completed the tally form and 99% by those who completed the 
individual form. Due to the fact that these surveillance forms had such a small amount of 
data missing from this item, it shows that health care professionals who completed both 
forms were effective in collecting data on those individuals who received the influenza 
vaccme. 
The question related to whether the patient received pneumococcal vaccine had 
the most missing data. However, the percentage of data missing from this question was 
still minimal with 7.4% of entries missing from tally forms and 6.1% missing from 
individual forms. There are several reasons why entries related to pnemoccocal vaccine 
were possibly missing. One reason may be due to the fact that, unlike the other 
questions, this information may not have been easily retrieved from patient files because 
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pneumococcal vaccine is not provided every year like the influenza vaccine. After the 
surveillance initiative began, a call was received from one physician who wanted more 
information about the pneumococcal vaccine. This physician felt that he did not know 
enough about the vaccine and when it should be offered to patients. He said that he was 
not the only physician he knew that would like more information on the vaccine. There 
is information sent out with the pneumoccocal vaccine every year and it is important that 
physicians read this information. Because physicians may not read the information 
provided to them, they may not know when to offer the pneumococcal vaccine to their 
patients. This may be another reason why there was more data missing on this question 
than any other question, because physicians who do not know when to offer the vaccine 
may avoid asking the patient if they had received the vaccine before, due to fear of the 
patient asking questions about the vaccine that they may not be able to answer. A third 
possible explanation for the missing data may be that individuals may not remember 
receiving the vaccine if they were asked about past pneumococcal vaccination. 
The accuracy of the data relates to whether the data obtained from the influenza 
immunization surveillance forms truly reflect that of each individual who received the 
influenza vaccine. The accuracy of the data obtained from the surveillance forms i.e. was 
the information true is a different issue than the completeness of the data obtained i.e. 
was the infmmation documented. However, the surveillance system's ability to provide 
accurate data is also important to consider. Accuracy of the data obtained is an important 
component because inaccurate data leads to an inaccurate estimate of those individuals in 
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the population who were actually vaccinated. The individual and tally forms required 
health care professionals to complete more specific data on the recipients of the influenza 
vaccine than the government form required. These forms had a space provided to 
indicate the patient's date of birth and space to indicate the reason why the patient was 
vaccinated. Four percent (78 of 1 ,950) of health care professionals identified age as the 
only reason why their patient received vaccine despite the fact that the individual 
receiving the vaccine was under 65 years of age. This was the only example of possible 
inaccurate data. It can only be assumed that the information provided by health care 
professionals was accurate since most health care professionals have a good knowledge 
of their patients and why they are receiving the vaccine. Therefore, other than the 4.0% 
discrepancy that was noted between the actual age being under 65 years and age 
identified as a reason for vaccination, there was no reason to doubt the accuracy of the 
information provided on the surveillance forms. 
It is important to determine which surveillance form provided the most useful 
influenza immunization surveillance data. The most useful information obtained from 
the surveillance forms would be the information regarding who received the influenza 
vaccine. Because there are multiple target groups who should receive influenza vaccine, 
it is important to ask questions on surveillance forms to distinguish between these target 
groups. The tally forms and individual forms had six questions which health care 
providers were expected to complete, whereas the government form only looked at 
whether the recipient was under or over 65 years of age. The data from the tally and 
individual forms allows one to summarize the reasons why individuals received the 
influenza vaccine. This information can be very useful if the appropriate denominator 
data is available, sin~e it provides good numerator data which helps in determining the 
proportion of individuals in certain target groups that are receiving influenza vaccine. 
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When reviewing the present tally and individual forms, there were two questions 
that were not related to the specific purpose of this surveillance system and could 
possibly be removed from the forms if they were to be used again in future influenza 
immunization surveillance initiatives. The recipient's gender could be removed from the 
form since it is not a risk factor for contracting the influenza virus and there is at present 
no difference in the methods used to promote vaccine uptake in males and females. 
However, if significantly more females receive the influenza vaccine than males, or vice 
versa, it would be important to add gender-specific strategies that target those who do not 
receive the vaccine in future influenza immunization promotional campaigns. Since 
gender is not time consuming to record the decision to keep or delete this question on 
future surveillance forms will have to be made by the Department of Health and 
Community Services if they deem it important to know if a gender specific difference 
exists. The recipient's specific date of birth could also be removed and replaced with an 
under 65 years and a 65 years of age and older category; the form would be easier to 
complete and the required information would still be obtained. It is important to keep the 
date the influenza vaccine was administered on the form because it may be helpful in the 
future to track when most of the vaccine was administered to guide interventions to 
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increase vaccine uptake for that season. 
The reasons why individuals received the influenza vaccine could be merged into 
fewer categories. Health care professionals could remain as a separate category since 
this is a group of individuals that has denominator data available. Therefore a 
vaccination rate for this group could be determined if future surveillance initiatives 
included institutions. Diabetes could also remain as a separate category because there is 
denominator data available forthis population. The other chronic diseases such as 
cardiac, pulmonary, renal disease and cancer could all be merged as one category called 
"chronic disease". Age could remain as a reason and an "other" category would remain 
so health care professionals could write in the reason why the vaccine was provided if it 
did not fit the other categories. The question of whether the patient received the 
influenza vaccine in the past should remain on the form. This question provides 
information regarding whether there is an increase in new vaccine recipients each year, 
or if health care professionals are continuously vaccinating the same individuals each 
year. In addition, the individual and tally forms had a question related to whether or not 
the patient received pneumococcal vaccine in the past. Retaining this question is 
discussed in the next section on flexibility. 
Overall, with respect to this criteria, the tally and individual forms were more 
useful than the government form. The completeness and accuracy of the information 
obtained was not a concern from either one of the three forms. Modifications could be 
made to further simplify the tally and individual forms without reducing the usefulness of 
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the data. This finding shows that the individual and tally forms provided the most useful 
information, suggesting that these would be the best forms to select if usefulness were the 
only criterion to consider in finalizing decisions about influenza immunization 
surveillance. 
Flexibility 
The criterion of flexibility, the system's ability to accommodate new diseases and 
health conditions, can be seen in the influenza immunization surveillance system used in 
this study (CDC, 2001 ). By including an extra question on the surveillance form, this 
system can easily accommodate other vaccines such as the pnemococcal vaccine. 
There are argumentsboth for and against retaining the question relating to 
whether or not the individual received pneumococcal vaccine in the past, which was 
presented on the tally and individual forms. The question can be removed if the future 
surveillance system's only objective is to collect influenza immunization data. Doing so 
would condense the form tohave fewer questions and possibly reduce the amount of 
missing data. 
There are a number of benefits to keeping this question on the surveillance form. 
Keeping this one extra question is a simplistic way to track two vaccines with one 
surveillance form. In addition, pneumococcal vaccine surveillance can be tied in with 
influenza immunization surveillance as a way to flag pneumoccocal vaccination as a 
topic for discussion between health care professionals and their patients. If patients see 
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this question on the form they may ask their health care professional about the vaccine 
and if they should receive it. As well, health care professionals may bring up 
pneumococcal vaccination to their patients more frequently. Because the results ofthis 
study showed that 4 7. 7% of those 65 years of age and older did not receive 
pneumococcal vaccine in the past, there is still work needed on promoting the 
administration of pneumococcal vaccine. Therefore, it may be important to keep this 
question on future surveillance forms as a way to promote pneumoccoal vaccine 
administration in the future. Ultimately the decision to delete or keep this question on 
future surveillance forms will have to be made by the Department of Health and 
Community Services when developing future surveillance initiatives. 
Representativeness 
In order to receive good quality influenza immunization data, the information 
obtained from returned surveillance forms must be representative of the recipient 
population. A surveillance system is representative if the data obtained from the system 
actually reflects that of the target population. An ideal way to have an influenza 
immunization system that obtains data that is representative of the entire population is to 
have 100% participation from health care professionals who administer the vaccine. 
Another way to obtain a representative sample is to select health care professionals that 
provide influenza immunization to a sample of patients who are representative of all 
those who receive the vaccine, and have these health care professionals collect influenza 
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immunization data. Without high participation from health care professionals, or a true 
random sample of the target population, the use of influenza immunization surveillance 
forms would not be an effective way to collect data that is representative of the 
population who receive the influenza vaccine, since a portion of the population would be 
left out. 
The overall participation in this study was 91.2% with 100% participation by 
community health nurses and 82.4% participation by physicians. Similar participation 
was seen in the study by Macdonald et al. (1996) with an overall participation of82.7% 
and 100% participation by public health nurses and 71 .9% by physicians. Therefore, in 
comparing these results, community health nurses have a higher participation rate in 
carrying out influenza immunization surveillance. 
There was 100% participation by community health nurses in this study, as well 
as in the study by Macdonald et al. (1996). Community health nurses in the Eastern 
Region ofNewfoundland and Labrador are familiar with participating in immunization 
surveillance since they provide· over 80% of the childhood immunizations in the region 
(personal communication, Patricia Heath, Communicable Disease Control Coordinator 
Eastern Region, November 24, 2002). When nurses provide the immunizations to 
children, they are required to collect and document yearly immunization surveillance 
data and send this information to the Communicable Disease Control Coordinator for 
data entry. Therefore, the process of collecting surveillance data is a very familiar one to 
community health nurses, and all of the community health nurses who participated in this 
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study felt that influenza immunization surveillance was a good idea, this may be the 
reasons why there was 100% participation from the nurses in this study. With a high 
participation rate, community health nurses are effective in collecting numerator data for 
those to whom they administer the influenza vaccine. Therefore, if there were more 
nurses administering influenza vaccine there may be a higher overall participation in 
influenza immunization surveillance which would in tum lead to more accurate 
numerator data. 
The participation by physicians in this study and in the study by Macdonald et al. 
(1996) was less than the 100% participation by nurses. Of the physicians who were 
distributed vaccine in this study, 82.4% completed and returned surveillance forms and 
71.9% of the physicians in the study by Macdonald et al. participated by returning forms. 
The physicians in this study were asked for feedback as to why they did not participate. 
Those who provided feedback stated that they did not receive the form on time and they 
misunderstood how to complete surveillance forms. Therefore, if physicians received the 
forms before surveillance began and better understood how the surveillance forms should 
be completed there may be an increase in participation by physicians in future 
surveillance initiatives. 
This present study was the first influenza immunization surveillance project of 
this nature in Newfoundland and Labrador and, therefore, showed high participation for 
the first time for such an initiative. If a similar surveillance initiative took place again 
there may be a higher participation rate as seen in the study by Macdonald et al. In their 
study, the overall response in the 1993 pilotproject was 47% and increased to 82.7% 
when the surveillance initiative was tried again in the most recent study. 
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This study was the only study that compared three different surveillance forms. If 
the government form was not includedin this study, and the study was carried out as it 
was originally planned, the participation rate would have been 62. 7%. This rate is still 
relatively high for the first time for such an initiative. There was very little difference 
noted in participation by physicians who originally received the individual, 52.6% 
(10/19) and tally, 47.4% (9/19) forms. The government form was sent to those who 
refused to complete the individual and tally form. Physicians were not forced to 
complete the government form but were encouraged to complete it if they had refused to 
complete the form they had been originally sent. 
This study achieved 91.2% participation from health care professionals who 
administer influenza vaccine. This participation rate suggests that it is possible to 
improve participation in the future influenza immunization surveillance initiatives and 
get close to 100% particiaption, which would ensure representativeness of the data. The 
alternative would be to try and obtain a representative sample of patients. This could be 
done by selecting health care professionals in the region that provide influenza 
immunization to a population that is representative of those who receive the influenza 
vaccine, and have these health care professionals collect influenza immunization 
surveillance data. A random selection of all health care professionals who administer 
influenza vaccine or using volunteers may be two other alternatives. The physicians who 
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are already involved in the influenza surveillance or those who have already been 
carrying out influenza immunization surveillance and keeping their own statistics for 
previous seasons, may be two examples of physicians who would be willing to volunteer. 
In either case, it would be still necessary to be sure of the representativeness of the 
patients they see. 
Generalizability of the patients of health care professionals who volunteer to 
participate in research or surveillance has not been well described. Green, Miller, Reed, 
Iverson, and Bailey (1993) evaluated the patients and practices of family physicians in a 
national practice-based research network to understand whether results from practice-
based research networks are likely to be relevant to other practising clinicians. The 
results of their ·study showed that overall, the two samples differed with respect to 
demographics and characteristics of patients, while problems, diagnoses, services, 
disposition, and time spent with patients were similar. Despite the fact that this study 
showed that practice-based research networks are sufficiently representative of family 
practice, there is not enough evidence to show that specific family practice physician 
clinics in areas of this province are representative of those in the entire region. 
Therefore, prior to selecting the health care professionals, the population served by the 
individual practices would need to be determined. 
One method to determine the patient population served by family practice 
physicians is to review the practices' client files and determine the type of patients 
seen in that particular area. This would provide the information required to select those 
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physicians who serve a population that is truly representative of individuals who receive 
influenza immunization. In order to obtain this information a separate study would be 
required, since the files would have to be reviewed before the appropriate physicians 
were recruited to conduct influenza immunization surveillance. Without this information 
it would be difficult to determine how to select practices or if the practices of physicians 
who volunteer to participate would be representative of those who receive influenza 
immunization. 
In summary, this study showed that because of the high participation from health 
care providers (91.2% ), the information received from the surveillance forms was fairly 
representative of those who received influenza vaccine. The results of this study and the 
study by Macdonald et al. (1996) show that there are several ways to help increase health 
care professionals' participation in influenza immunization surveillance. Determining 
ways to increase participation to close to 1 00% will lead to a greater representation of 
those who receive the influenza vaccine in future seasons. It may be easier to try the 
strategies recommended by this study's conclusion and improve participation than to try 
and find health care professionals whose patients are representative of the target 
population. 
Timeliness 
The timeliness of a surveillance system should be evaluated in terms of the 
availability of information to identify trends, outbreaks, or the effects of control efforts. 
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The need for a rapid response in a surveillance system depends on the nature of the 
problem under surveillance and the objectives of the system. It is important to receive 
the influenza immunization data as early in the influenza season as possible, since data 
specific to that year could help guide interventions to increase vaccine uptake during that 
particular influenza season. There was no data collected in this study which related to 
when the forms were actually returned. It is therefore not possible to determine ifthe 
forms were returned in a timely manner. 
The majority of the vaccine was known to have been administered in October and 
November of the 2001-2002 influenza season. It would, therefore, be beneficial to have 
health care professionals return their surveillance fonns at the end of every month and 
then the majority of surveillance forms would be returned by the end of the first two 
months of the influenza season. Ensuring a timely return of surveillance forms would be 
an important component to add to future influenza immunization surveillance systems. 
Conclusions Regarding Improving Influenza Immunization Surveillance 
Influenza immunization surveillance in general was seen as a good idea by health 
care professionals in the Eastern Region. All of the community health nurses were 
strongly in favour and understood the importance of influenza immunization 
surveillance. The majority of physicians felt influenza immunization surveillance was 
important, with only a few who could not see the importance of surveillance and who 
would not like to see such an initiative added to their current workload. Therefore, it is 
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important to educate these physicians about the importance of influenza immunization 
surveillance to help increase their willingness to participate in future surveillance 
initiatives. Overall, however, the findings from this study support continuing with the 
influenza immunization surveillance system initiated for this study with three changes. 
The government form, although it accounted for the highest proportion of 
documented doses, did not provide information about reasons why individuals received 
the influenza vaccine. In comparing the tally and the individual forms, those who 
completed the tally form accounted for a statistically significant higher proportion of 
administered vaccine than those who completed the individual form (p<0.0005). Both 
forms provided useful information regarding why individuals received vaccine and one 
form had no more missing data than the other. Those who completed the individual form 
were less accepting of the form, since they felt there was too much paper used and they 
would have liked to see the form as a tally format. Health care professionals also 
wanted to see fewer categories on the surveillance forms. Therefore, to increase 
acceptance of the surveillance system in future seasons, the tally form should be used 
with the modifications previously described. 
In addition, to obtain influenza immunization data, it is important that the 
Department of Health and Community Services develop a method and policies as 
necessary of surveillance to account for unused vaccine in future surveillance initiatives. 
Accounting for unused vaccine will help determine the true sensitivity of the surveillance 
system used, as well as provide a true picture of those target groups who receive 
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influenza vaccine. The Department ofHealth and Community Services must also be 
willing to provide human resources to collect and analyse the data which is obtained 
from an influenza immunization surveillance system. These human resources, along with 
an influenza immunization surveillance system that bas been evaluated as being effective 
in meeting its overall objectives, will aid in collecting good quality data in future 
influenza immunization seasons. 
Finally, to increase the representativeness of the surveillance system used in this 
study, it is important to try to increase participation to have all health care professionals 
who administer influenza vaccine provide influenza immunization surveillance data. 
This may be easier to achieve than selecting health care professionals in the region who 
administer the influenza vaccine to a population that is representative of those who . 
receive the vaccine and have them collect influenza immunization data. Community 
health nurses had a higher participation rate than physicians which supports having more 
influenza vaccine administered by community health nurses as a way to increase the 
participation rates of future influenza immunization surveillance systems. Increasing the 
amount of vaccine administered by community health nurses could only occur if there are 
extra human resources available to help with the increased workload that would result 
from increasing the number of influenza vaccines that they would have to administer. 
Providing information, support, and resources to all health care professionals should help 
increase participation as well as the overall effectiveness of the surveillance system. 
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Improving Surveillance of Target Groups 
The focus of this study has been on collecting numerator data. However, to 
determine the proportion of vaccine eligible groups who receive influenza vaccine, one 
must not lose sight of the importance of denominator data. In order to calculate this 
proportion, the number of doses of influenza vaccine administered and to whom they 
were administered is required (numerator data) as well as the number of individuals 
eligible for the vaccine (denominator data). The proportion of vaccine eligible groups 
who received influenza vaccine was difficult to determine from the results of this study 
as there were problems with both numerator and denominator data. 
The first problem with numerator data was that there were nine physicians who 
did not participate. These physicians received 3,040 doses of influenza vaccine. This 
vaccine could not be included in the numerator which would alter the calculated 
proportions. Another problem was that the government form only provided information 
on whether or not individuals who received vaccine were under 65 or 65 years of age and 
older. Age was the only item that all three forms had in common. When calculating the 
proportion of the other target groups vaccinated, such as diabetics, individuals with 
cardiac and pulmonary disorders, the 2,123 doses administered to individuals by health 
care professionals who completed the government form could not be included because the 
required information about health conditions was not available. Both of these problems 
contribute to an error when calculating the total proportion of groups vaccinated because 
a total of 5, 163 doses were not included in the numerator. It is important to choose an 
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influenza immunization surveillance form that provides information on why individuals 
receive influenza immunization. 
Another problem with calculating the proportion of target groups vaccinated lies 
with the lack of appropriate denominator data. This particular study was carried out in 
the 2001-2002 season. The last census data published for Health and Community 
Services, Eastern Region, of the province ofNewfoundland and Labrador was in 1996. 
There will be data available for the 2001 year, however, it was not available when this 
data was required. If the data were available earlier, or ifthere were no time constraints 
on submitting the findings of this study, the researcher could have waited and used the 
2001 census data to calculate the proportion of individuals 65 years and older who 
received influenza vaccine. The denominator data available from the 1996 census data 
may not be the same as the data for 2001. Therefore, the actual proportions may be 
higher or lower than those calculated with the 1996 data, depending on if there was an 
increase or decrease in the target population. 
There is not a lot of data available on the number of individuals living in the 
community with chronic diseases. The data is even more difficult to collect when the 
data needs to be broken down into provincial regions. Data on the number of individuals 
living in the community with diabetes was available for this study. 
Denominator data for cardiac and pulmonary disorders and cancer was only 
available through hospital separation data. This denominator data would not be 
appropriate because it would not be representative of the individuals who received 
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vaccine in the community. If this data was used, one must assume that those who 
received influenza vaccine were hospitalized for their diagnosis which warranted them to 
receive the vaccine. This was a large assumption to make, therefore, the proportion of 
individuals from these target groups could not be calculated from the data collected from 
the surveillance forms. Recommended changes to forms that would include merging 
categories because data is not available for all chronic conditions. These changes would 
match the denominator data that is available, which would help determine proportion of 
these target groups that are vaccinated. 
The participation rates in this study were high for the first implementation of an 
influenza immunization surveillance system. Therefore, the information received from 
the influenza immunization surveillance forms was fairly representative of those who 
receive the influenza vaccine. However, with insufficient region specific denominator 
data on individuals in the region who are living with chronic conditions, it was difficult 
to determine proportions of individuals in certain target groups who received influenza 
vaccine in the 2001-2002 season. This study's purpose was to collect numerator data on 
those who receive the influenza vaccine and not denominator data. However, it would be 
beneficial to conduct further studies which could focus on determining region specific 
denominator data for those individuals who live with chronic disease. 
Improving Vaccination of Target Groups 
Once numerator and denominator data is improved, the proportion of individuals 
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who receive influenza vaccine will be more easily determined. This information can then 
be used to focus influenza immunization promotional campaigns on those groups who are 
not receiving influenza immunization. The results of this study indicated that only a 
small proportion of diabetics (10.7%) and individuals 65 years of age and over (25%) 
residing in the Eastern Region ofNewfoundland and Labrador received influenza 
vaccination in the 2001-2002 season. These low influenza immunization rates show that 
further research is required to determine why these vaccine eligible groups did not 
receive vaccination. These groups may require influenza immunization promotional 
campaigns to help increase vaccine uptake. 
Community health nurses should be utilized to help increase influenza 
immunization rates. Community health nurses can implement influenza immunization 
promotional campaigns to help increase vaccine uptake by those individuals who 
currently do not receive influenza vaccination. Community health nurses could also 
provide structured influenza immunization clinics to these individuals. The community 
health nurses would complement physicians who presently administer influenza vaccine, 
since they could administer vaccine to those who previously did not receive influenza 
vaccination. This would decrease the burden that could potentially be added to 
physicians' workloads, while expanding the role of the community health nurse in 
influenza immunization. 
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Strengths Qf the Study 
The main strength of this study was the high participation from health care 
professionals. The overall participation in this study was 91.2% which was very high, 
considering it was the first time influenza immunization surveillance was carried out. 
There was 100% participation by community health nurses and 82.4% by physicians. 
The surveillance system used in this study was a very simple system in which health care 
professionals were sent surveillance forms with their vaccine order along with stamped · 
addressed envelopes to return forms. The health care professionals were also sent 
monthly reminders to return forms. This simplistic system as well as health care 
professionals' acceptance of the system, all helped increase their participation. With 
high participation from health care professionals who administered the influenza vaccine, 
the information received from the surveillance system used in this study should be fairly 
representative of those who received influenza vaccine. 
Another strength of this study was that it compared three surveillance forms and 
obtained feedback from health care professionals about the surveillance forms. There 
were no other studies found in the literature on influenza immunization in the community 
that compared surveillance methods, nor were there any studies that obtained feedback 
from health care professionals. Comparing the forms to determine which form provided 
the most useful information helped in deciding which form was the best form to 
recommend for future surveillance initiatives. By obtaining feedback from those health 
care professionals who administered influenza vaccine, it helped determine which form 
was most accepted and it also provided an opportunity for health care professionals to 
give their opinions on the surveillance system used. 
Limitations of the Study 
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There was one key limitation of this study. There were 5,656 doses of influenza 
vaccine unaccounted for and there was no system in place to determine if this vaccine 
was actually wasted or administered. If the vaccine was wasted and discarded by health 
care professionals, it would change the sensitivity of the overall surveillance system, 
because all the vaccine administered would have been accounted for by the surveillance 
forms used. This would increase the overall sensitivity of the system. Therefore, in 
future influenza immunization surveillance initiatives it is important to have a 
mechanism in place to track vaccine that is unaccounted for. This unaccounted for 
· vaccine also lead to incomplete numerator data, as discussed previously in this chapter. 
Implications of the study's findings are discussed in the following chapter. 
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CHAPTER6 
Implications for Practice, Policy, Education, and Research 
This chapter focuses on the implications of this study's fmdings . The first section 
summarizes the discussion of the study's findings found in chapter five. This is followed 
by several sections which present the implications for community health practice, policy, 
education, and research. Finally, there is section presenting the overall recommendations 
ofthis study. 
Summary of Discussion of Study Findings 
The results of this study were discussed in relation to the CDC (200 1) guidelines 
for evaluating a surveillance system. The first criterion used to evaluate the surveillance 
system was sensitivity. This study's results showed that the overall sensitivity of the 
surveillance system used was fair, with a possibility of a higher sensitivity if the . 
unaccounted for vaccine was actually unused. The sensitivity differed depending on who 
completed the form, and which form was completed. When community health nurses 
utilized the surveillance system, the sensitivity was shown to be higher. Those who 
completed the government form accounted for statistically significantly more 
administered and administered + returned vaccine than those who completed the tally and 
individual forms (p<0.0005). 
The second criterion used to evaluate the surveillance system was the positive 
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predictive value. The positive predictive value in this surveillance system was the 
proportion of individuals documented as receiving influenza vaccine that actually 
received the vaccine. For the surveillance system used in this study, there was no reason 
to believe that the positive predictive value was low. 
The simplicity and acceptability of the surveillance system was also discussed 
and the overall feedback from health care professionals showed that the influenza 
immunization surveillance forms were a simple and acceptable way to collect influenza 
immunization data. Time was not an issue for health care professionals when completing 
the forms, and of the individual and tally forms, the tally form was the form they would 
like to see used again. 
The criterion of flexibility, which refers to the system's ability to accommodate 
new diseases and health conditions, was seen in the influenza immunization surveillance 
system used in this study (CDC, 2001 ). The question relating to whether or not the 
individual received pneumococcal vaccine in the past was on the individual and tally 
forms. This showed the surveillance system used in this study was flexible since it was 
able to accommodate other vaccines. Accommodating other vaccines on future 
surveillance forms would depend on whether or not it was seen as important by the 
Department of Health and Community Services. 
The surveillance forms provided information that was fairly representative of 
those who received the influenza vaccine, because of the high participation rate (91.2% ). 
Community health nurses had a higher participation rate than physicians in this study. 
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With such a high participation rate, it would be easier to try to increase participation to 
100% in future influenza immunization surveillance systems than to try and obtain a 
representative sample of patients. 
The final criterion used to evaluate the surveillance system was timeliness. There 
was no data collected in this study which related to when the forms were actually 
returned. However, ensuring a timely return of surveillance forms would be an important 
component to add to future influenza immunization surveillance systems, since collecting 
data specific to the season would help guide interventions to increase influenza vaccine 
uptake during the same season. 
In conclusion, the system's overall sensitivity may be increased if future 
influenza immunization systems implement a method to account for unused vaccine. 
There was no reason to believe the positive predictive value was low. The system that 
was used was simple and accepted by the majority of those who used it and provided 
feedback, and the system was shown to be flexible in that it can easily accommodate 
other vaccines. The system provided fairly representative data, however it can be 
improved if the participation increases to closer to 100%. There was no data collected on 
when the forms were returned, however timeliness would be an important criterion to use 
to evaluate future surveillance systems. This study's findings support continuing with 
influenza immunization surveillance, using a similar system, while incorporating the 
recommendations suggested. 
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Implications Practice in a Community Setting 
This study has several implications for practice in a community setting. It is 
important for health care professionals practising in the community to continue with 
influenza immunization surveillance. The influenza immunization tally form used in this 
study, with the recommended changes, would be the ~est surveillance form to use in 
future influenza immunization surveillance systems. 
Another implication for community health practice is to implement a method for 
health care professionals to account for all unused vaccine at the end of the influenza 
season. Accounting for the vaccine that was unused during a particular influenza season 
is important because it would help in providing more accurate numerator data, since the 
administered vaccine and the administered + returned vaccine would add up to be 100% 
of the vaccine distributed. It is recommended that if health care professionals do not 
return unused vaccine, they should have to complete a form at the end of the season 
stating the amount of vaccine unused. If they do not do this and the vaccine documented 
as administered does not add up to the vaccine distributed, they should only receive the 
amount of vaccine documented as administered in future seasons. In addition, if health 
care professionals are sending back a lot of unused vaccine, health boards who are 
receiving the unused vaccine ·should contact these offices to determine why they had such 
a large amount of vaccine returned. This monitoring process may help health care 
professionals become more aware of their actual vaccine usage and needs, leading to 
more realistic requests for vaccine in the future. This monitoring, coupled with the 
Health and Community Services Board sending health care professionals amounts of 
vaccine in keeping with previous usage, should reduce the amounts of unused vaccine 
and the associated costs. 
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Participation of community health nurses in influenza immunization surveillance 
was not a problem in this study because there was 100% participation by community 
health nurses. The greater issue is to increase conununity health nurses involvement in 
influenza vaccine delivery. Community health nurses are familiar with conducting health 
promotion activities, and should be utilized as a way to help increase influenza 
immunization. There were two vaccine eligible groups, those 65 years of age and older 
(25.0%) and diabetics (10.7%), identified as having low influenza vaccination rates in 
this study. Community health nurses can implement influenza immunization 
promotional campaigns and provide influenza immunizations to these individuals, and to 
others who currently do not receive influenza vaccination. This would not decrease the 
amount of influenza vaccine that is currently provided by physicians. Instead, the nurses 
would complement them by administering vaccine to those individuals who previously 
did not receive influenza vaccination. This would decrease the burden that could 
potentially be added to physicians' workloads, while expanding the role of the 
community health nurse in influenza immunization. 
In order to utilize more nurses to administer influenza vaccine there must be an 
increase in resources. Community health nurses would require more human resources to 
carry out larger influenza immunization clinics. These human resources would only be 
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required when influenza vaccination clinics take place. 
Finally, it is important to provide feedback to health care professionals of the 
results of the influenza immunization surveillance data received after each influenza 
season. Health care professionals will be able to utilize this data as a way to increase 
influenza immunization of those who did not receive the vaccine. It will also promote 
the importance of collecting influenza immunization data, and show health care 
professionals how the data can be utilized. 
Implications for Policy 
It is important that the Department of Health and Community Services utilize a 
mandatory system, with supportive policies, to collect influenza immunization data. 
With participation being a key component in the collection of influenza immunization 
data that is representative of those who receive the vaccine, there may be a need for the 
Department of Heath and Community Services to implement mandatory influenza 
immunization surveillance. This may be a way to increase participation and lead to a 
more accurate calculation of the proportion of target groups who received the vaccine. 
One of the first initiatives toward developing a national immunization strategy 
should be to create a reliable, up to date electronic registry system for immunizations 
(Embree, 2001). This electronic registry would ideally enable vaccine providers to 
determine which vaccines their patients had actually received and when, regardless of 
where they had been immunized. These registries would also provide powerful tools to 
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monitor the effects of immunization on disease incidence. Despite the fact that electronic 
recording would be an efficient method to collect influenza immunization data, the 
feasibility of implementing such a system quickly in this province is low because very 
few physicians in this province presently have computers and therefore would not be able 
to record influenza immunization data electronically. Once health care professionals 
have the technology available to enter this information, computerized recording could 
become a much more efficient way to carry out future influenza immunization 
surveillance. The tally form used in this study would be the recommended method of 
influenza immunization surveillance until the proper technology is available to health 
care professionals. 
Another implication of this study's findings for policy relates to funding. If 
health care professionals are going to have to carry out influenza immunization 
surveillance and conduct influenza immunization promotional campaigns, to increase 
influenza vaccine uptake in those who are not receiving the vaccine, there will be extra 
resources required. It would, therefore, be important for the Department of Health and 
Community Services to advocate for more funding so health care professionals can carry 
out influenza immunization surveillance each year and conduct influenza immunization 
programs on a larger scale. 
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Implications for Education 
Ongoing education about the importance of influenza immunization surveillance 
is needed for health care professionals who provide influenza vaccination. This may 
increase health care professionals' participation in influenza immunization surveillance 
because it will increase their awareness about the importance of the influenza 
immunization surveillance data they are collecting. 
It is important to continue to place an emphasis on immunizations, particularly 
influenza, in the educational programs of health disciplines that are involved in 
providing and promoting immunization. This will increase the knowledge nurses and 
other health care professionals have about immunizations and the important role they 
play in the administration and collection of immunization surveillance data. Community 
health nurses who are currently practising may also need some additional information 
about the influenza vaccine because many nurses may not have had to administer the 
vaccine in recent years. It would be important to survey community health nurses to 
determine any continuing education they may need about the influenza vaccine, 
especially if they began to carry out larger scale influenza immunization clinics. 
This study found that most of the data that were missing from the forms were 
related to whether or not the patient received pneumococcal vaccine in the past. There 
were several reasons why the majority of data were missing from this question. 
Physicians may not have read the information provided to them about pneumococcal 
vaccine and therefore may not know when to offer this vaccine to their patients. 
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Physicians who do not know when to offer the vaccine may avoid asking the patient if 
they had received the vaccine before, due to fear of the patient asking questions about the 
vaccine that they may not be able to answer. During this study a physician called and 
stated that he did not know enough about the pneumococcal v_accine to know when it 
should be offered to patients. Therefore, it is recommended to survey health care 
professionals in the region as a way to determine those who require continuing education 
about pneumococcal vaccine. This would identify those who need education so they 
could be sent the information that they need on the vaccine. 
Finally, it is important to educate patients about the importance of receiving 
yearly influenza vaccinations. This education may take place one on one with health care 
professionals or through larger influenza irnmuruzation promotional campaigns. Patient 
education will help alleviate any misconceptions patients may have about the influenza 
vaccine, as well as increase their knowledge about the vaccine and its benefits. This may 
help increase vaccine uptake in those who presently do not receive the vaccine. 
Implications for Research 
The results of this study have suggested further research is required in areas 
related to vaccine eligible groups and who should administer the influenza vaccine. One 
of the limitations of this study was difficulty knowing who received the influenza 
vaccine. Therefore, it is important to increase research in areas that would expand region 
specific denominator data for specific chronic conditions. Presently there is no region 
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specific denominator data available for conditions such as: cancer, pulmonary disorders, 
cardiac conditions, and renal disease. This data would enable future influenza 
immunization systems to determine the proportion of target groups vaccinated, and 
therefore help health care professionals plan ways to target influenza immunization 
promotional campaigns on those who do not receive the vaccine. In addition, it would be 
important to understand why certain vaccine eligible groups are not receiving the 
influenza vaccine. This would help determine methods to increase influenza vaccination 
in those who presently do not receive the vaccine. 
The results of the study showed that community health nurses were effective in 
collecting surveillance data. Community health nurses are familiar with childhood 
immunizations and are effective in collecting surveillance data related to these 
immunizations. Further research is required to determine if community health nurses are 
as familiar with the influenza vaccine as they are childhood vaccinations. If community 
health nurses are familiar with the influenza vaccine, it would be important to conduct a 
study to compare community health nurses to physicians in terms of their knowledge of 
influenza immunization, storage of the influenza vaccine, and the proportion of unused 
vaccine. In addition, it would be beneficial to determine the cost ofhaving community 
health nurses administer influenza vaccine compared to physicians. By conducting such 
a study, it may help determine which health care professionals are the most appropriate to 
administer influenza immunizations. 
If community health nurses are as effective as physicians in the overall delivery 
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of the influenza vaccine it would be beneficial to increase the role of the community 
health nurses in administering the influenza vaccine. In order to increase community 
health nurses involvement in vaccine delivery, there must be further research completed 
on how to increase their involvement. 
Overall Conclusions 
In conclusion, it is recommended that the Department of Health and Community 
Services implement an influenza immunization surveillance system across the province 
of Newfoundland and Labrador. Influenza immunization forms are the surveillance 
method of choice and the same influenza immunization surveillance form should be used 
across all regions of the province. The form should be presented in a tally style format 
containing 5 questions. The questions on the future tally style form would consist of: 
date of immunization, whether patient is under 65 years of age or 65 years of age and 
over, if patient received influenza vaccine last year, if patient received pneumococcal 
vaccine in past and what was the reason for influenza immunization. The reasons for 
vaccination should be listed in categories that have denominator data available, until 
more region specific denominator data becomes available for certain individuals living 
with chronic diseases such as cardiac and pulmonary disorders. 
The forms should be sent to all health care professionals who administer the 
vaccine or to a sample of health care professionals who administers the vaccine to a 
population that is representative of influenza vaccine recipients. Both methods would 
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help obtain a sample that is representative of those who receive the influenza vaccine. 
When using a random sample or if distributing forms to all health care professionals, it is 
important to utilize techniques that help enhance participation. Such techniques should 
include: using a structured system that explains the surveillance initiatives, returning 
forms to the MOH, sending out monthly reminders to return forms and obtaining 
feedback from participants to determine their opinions on the surveillance system used. 
In addition, it is important to make the surveillance system as simple as possible. The 
simpler the system, the more acceptable it will be to health care professionals. This will 
lead to greater participation from health care professionals who administer the influenza 
vaccme. 
Finally, it is important to evaluate the surveillance systems used in future 
influenza immunization surveillance initiatives. Evaluating the surveillance system in 
terms of the seven criteria identified by the CDC (200 1) guidelines for evaluating a 
surveillance system, will assess whether the system is serving a useful purpose while 
meeting the surveillance system's overall objectives. 
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Appendix A 
Logic Model 
Influenza Immunization Surveillance Form 
( doses administered I doses distributed ) 
Other Surveys · 
(Population Health Survey) 
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Number of Individuals Vaccinated Number of Individuals Eligible for 
Vaccination 
Proportion of Eligible Groups Vaccinated 
(Number oflndividuals Vaccinated I Number of Eligible Individuals) 
Identification of Target for Influenza Immunization Campaign to Increase Coverage 
Increased Influenza Vaccination Rates 
Influenza Immunization Surveillance Form 
2001 - 2002 Season 
r-·· 
Date of 
Reason for Immunization 
hnmunization Gender Date o l Cardiac Pulmonary Diabetes Cancer Renal Disease Resident of Long 
( Y /tv1 I D ) Birth Disorder Disorder Term Care Facility 
- ---
M F 
M F 
M F 
f--·-
M F 
M F 
M F 
M F 
-
M F 
M F 
M F 
M F 
M F 
*Please Check the appropriate box to indicate reason for immunization 
Return completed forms to Dr. Catherine Donovan 
Medical Officer of Health 
PO. Box 70 
Holyrood, NF AOA 2RO 
Health Care Age 
Stall 
Did patient receive 
Other influenza vaccine 
last yea(/ 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Did patient ever receive 
pneumococcal vaccine? 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Economy 
{"109) 250 
No 
No 
No 
No 
No 
No 
-
No 
No 
No 
No 
No 
No 
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Influenza Immunization Surveillance Form 
2001 - 2002 Season 
Please complete one form for each patient who receives influenza vaccine this season . 
Date of Influenza Vaccination 
(YYYY/MM / DD ) 
Did Patient receive Influenza Vaccine last year? 
Date of 
Birth: 
Gender: 
Yes No 
Did Patient ever receive Pneumococcal Vaccine? 
M F Yes No 
Please check the appropriate blank to indicate reason for immunization 
Reason For Influenza Immunization 
Chronic Cardiac Disorder 
Chronic Pulmonary Disorder 
Resident of Long Term Care Facility 
Cancer 
Diabetes 
Renal Disease 
Health Care Provider 
Child treated for long periods with ASA 
Traveller 
Age 
Other 
Return completed forms to Dr. Catherine Donovan 
Medical Officer of Health 
PO. Box 70 
Holyrood, NF 
AOA 2RO 
1\, I 'J 0938 I 1 -
Economy Prin ting L!d. , Gander, NF 
{709} 255-21,5 
Appendix D: 
13 5 
TALLY SHEET 
for recipients oflnfluenxa Vaccine Fall- 2001 Health care provider 
Please complete at the end of your clinic day 
Date # doses for 65 and over # doses for those of any age -with chronic illness 
Total 
When complete please fax to : -------------------------
August 7, 2001 
Dear Doctor/Nurse: 
Appen~ix E: Letter from MOH 
~~-- ·. ~ l.,_;l.i~ 
HEALTH i\ND COIVJNfUNITY SERv1CES 
EASTERN BOARD 
Health Promotion/Protection Division 
P.O. Box 70, Holyrood, NF, AOA 1RO 
Tel: (709) 229-1573 Fax: (709) 119-1591 
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Enclosed is information regarding influenza immunization and vaccine order forms for the 
upcoming influenza season. As an additional feature of the program this year, Eastern is 
participating in an influenza immunization surveillance project. As you are aware, the region and 
the province as a whole has little information on the real rates of immunization for influenza, we 
only know how much vaccine is distributed. As we plan for Pandemic Influenza, it is critical for 
us to have a better understanding of who is actually being immunized and how successful our 
efforts are. This is necessary not only to anticipate the impact of pandemic influenza but also t o 
develop targeted promotional campaigns to improve immunization rates and ultimately to 
decrease the impact of an outbreak. Your collaboration in this effort is essential. 
Further information on this special project is enclosed. The project requires the collection of 
minimal information on the patients to whom you provide vaccine. I am requesting that you 
return this information to me. Specific directions will accompany your vaccine. 
Should you choose not to participate in this project, you will receive your vaccine as usual 
however your contribution will make it possible for us to design future surveillance activities 
which are most suitable for you. Your participation is critical to our success. 
Thank you in advance for your anticipated cooperation. 
Sincerely yours, 
Catherine Donovan, M.D ., M.H.Sc. 
Medical Health Officer 
CD/sd 
E ncl. 
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Appendix F: 
Letfer of Explanation From Investigator 
Dear Health Care Provider; 
I am a Masters student at Memorial University's School ofNursing and I am conducing a 
research study on influenza immunization surveillance. This study is supported by Eastern 
Health and Community Services as a part of an influenza immunization initiative. This study is 
to assess a mechanism of influenza immunization surveillance. 
Participation in this study requires that you complete a surveillance form for each patient that 
receives the influenza vaccine in your clinic/practice. The forms are very simple to complete 
and will only take a couple of minutes per patient. The forms will then be returned in stamped 
addressed envelopes provided to you. Participation in this study will give you an opportunity to 
provide feedback and input into a surveillance system. 
For further details on this study please see the attached study explanation. lfyouhave ,any 
further questions on this study please feel free to call me at --WE will be 
calling you the week after you receive your vaccine and in11uenza immunization surveillance 
forms, and we will send you fax reminders every month unless you notify us otherwise. 
Sincerely, 
Suzette Porter 
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Appendix G: 
Respondent Telephone Interview Questionnaire 
1. Were you able to account for all tlie influenza vaccines you administered this season by 
using the influenza immunization surveillance form? Why or why not? 
2. Is this the surveillance form you would like to see used if influenza immunization 
surveillance continues in future seasons? Why or Why not? 
3. Who completed the influenza immunization surveillance forms? 
4. What is you opinion on influenza immunization surveillance in general? 
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Appendix H: 
Non Respondent Telephone Interview Questionnaire 
1. If influenza immunization surveillance continued what changes would you make in the 
forms or data collection process? 
2. What is your opinion on influenza im.rllunization surveillance in general? 
Appendix I: Letter of Financial Support 
HEALTH AND C01v~HJNITY SERv1CES 
EASTERN BOARD 
Health Promotion/Protection Division 
P.O. Box 70, Holyrood, NF, AOA 2RO 
Tel : (709) 229-1571/72 Fax: (709) 229-1591 
MEMO 
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RE: Re: Masters Thesis"Tracking Influenza Immunization in the Community", 
Suzette Porter 
FROM: 
DATE: 
Catherine Donovan, Medical Health Officer 
August 7, 2001 
Health & Community Services, Eastern Region wishes to express its full support for this project 
proposal. The results of the project will help to provide information that will be immediately 
helpful to us in terms of increased knowledge about immunization coverage and will also be useful 
in planning future surveillance strategies. The project will also provide data of relevance to other 
regions and the province. This project is very timely in light of current initiatives related to 
planning for Pandemic Influenza. 
This organization will provide in-kind financial contributions through administrative support in 
addition to promoting the project during our influenza immunization campaign. 
-::..;..,.~~-~----
Catherine Donovan, M.D., M.H.Sc. 
Medical Health Officer 
CD/sd 
Appendix J: Letter of Approval from HIC 
Memor1al 
University of Newfoundland 
Human Investigation Committee 
Research and Graduate Studies 
Faculty of Medicine 
The Health Sciences Centre 
August 29, 2001 
Reference #01.146 
Ms. Suzette Porter 
P.O. B.ox 364 
Manuels, NF 
AlW 1M9 
Dear Ms. Porter: 
141 
At a meeting held on August 23, 2001, your application entitled "Tracking Influenza 
Immunization in the Community" was reviewed by the Human Investigation Committee. 
The Committee granted approval of the application noting the potential difficulty in receiving 
a high response rate. A small note was made that Dr. Catherine Donovan is also a supervisOr 
on this thesis study. This was not noted in the application. 
Sincerely, 
Sharon K. Buehler, PhD 
Co-Chair 
Human Investigation Committee 
S KB: CP\j glc 
Catherine Popadiuk, M.D., F.R.C.S.(C) 
Co-Chair 
Human Investigation Committee 
C Dr. C. Loomis, Acting Vice-President, Research 
Dr. R. Williams, Vice-President, Medical Services, HCC 
Dr. D. Moralejo, Supervisor 
St. }ohn"s . N F. Canad a AlB 3V6 • Tel.: (7091 777-6974 • Fax: (7091 777-7501 




